WO2021051349A1 - Method for analysis of animal blood cells, analyzer, and storage medium - Google Patents
Method for analysis of animal blood cells, analyzer, and storage medium Download PDFInfo
- Publication number
- WO2021051349A1 WO2021051349A1 PCT/CN2019/106669 CN2019106669W WO2021051349A1 WO 2021051349 A1 WO2021051349 A1 WO 2021051349A1 CN 2019106669 W CN2019106669 W CN 2019106669W WO 2021051349 A1 WO2021051349 A1 WO 2021051349A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- animal
- blood
- dose
- diluent
- tested
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 334
- 210000000601 blood cell Anatomy 0.000 title claims abstract description 83
- 238000000034 method Methods 0.000 title claims abstract description 56
- 238000004458 analytical method Methods 0.000 title claims abstract description 23
- 210000004369 blood Anatomy 0.000 claims abstract description 157
- 239000008280 blood Substances 0.000 claims abstract description 157
- 239000003085 diluting agent Substances 0.000 claims abstract description 153
- 238000012360 testing method Methods 0.000 claims abstract description 129
- 238000005259 measurement Methods 0.000 claims abstract description 127
- 210000000265 leukocyte Anatomy 0.000 claims abstract description 40
- 206010018910 Haemolysis Diseases 0.000 claims abstract description 23
- 230000008588 hemolysis Effects 0.000 claims abstract description 23
- 238000004820 blood count Methods 0.000 claims abstract description 17
- 210000004027 cell Anatomy 0.000 claims description 87
- 210000003850 cellular structure Anatomy 0.000 claims description 82
- 238000005070 sampling Methods 0.000 claims description 60
- 239000003219 hemolytic agent Substances 0.000 claims description 56
- 239000003153 chemical reaction reagent Substances 0.000 claims description 55
- 210000003743 erythrocyte Anatomy 0.000 claims description 17
- 238000013166 platelet test Methods 0.000 claims description 8
- 238000001514 detection method Methods 0.000 abstract description 8
- 239000000523 sample Substances 0.000 description 76
- 210000004698 lymphocyte Anatomy 0.000 description 23
- 239000007788 liquid Substances 0.000 description 15
- 241000282326 Felis catus Species 0.000 description 11
- 239000012895 dilution Substances 0.000 description 8
- 238000010790 dilution Methods 0.000 description 8
- 238000010586 diagram Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000001616 monocyte Anatomy 0.000 description 6
- 241000282472 Canis lupus familiaris Species 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 230000006870 function Effects 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000012805 animal sample Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 210000003714 granulocyte Anatomy 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- -1 quaternary ammonium salt ion Chemical class 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
Definitions
- the embodiment of the present invention relates to animal blood cell analysis technology, and relates to but is not limited to an animal blood cell analysis method, analyzer and storage medium.
- the main principle of animal blood cell analysis is to test the parameters of white blood cells, red blood cells and platelets on the diluted animal blood samples through micropores.
- an animal blood cell analyzer On an animal blood cell analyzer, blood samples of dogs, cats, rats, mice, rabbits and other animals need to be tested. However, the hemolysis process of the white blood cell channel of each animal is different. Therefore, in related technologies, an animal blood cell analyzer cannot guarantee the accuracy of the white blood cell count and classification results.
- the embodiment of the present invention provides an animal blood cell analysis method, analyzer and storage medium to improve the accuracy of white blood cell count and classification results of different types of animals.
- the embodiment of the present invention provides an animal blood cell analysis method, which is applied to an animal blood cell analyzer, and the method includes:
- test sample is tested to obtain white blood cell count and classification results.
- the embodiment of the present invention provides an animal blood cell analyzer.
- the animal blood cell analyzer includes:
- the sampling needle assembly is used to suck the blood of the animal to be tested and send it to the first counting cell assembly;
- the mode selection module is used to select a target measurement mode from a variety of animal measurement modes, and determine the target dose of the diluent according to the target measurement mode;
- a reagent delivery component which is used to mix the diluent of the target dose with the blood of the animal to be tested, and perform hemolysis treatment to obtain a test sample;
- the first counting cell component is used to test the test sample to obtain the white blood cell count and classification results.
- An embodiment of the present invention provides a storage medium with an executable program stored on the storage medium, and when the executable program is executed by a processor, the steps of the animal blood cell analysis method executed by the animal blood cell analyzer are implemented.
- the target dose of the diluent used to dilute the animal’s blood is determined based on the animal measurement mode corresponding to the animal species, so that the target dose of the diluent is used to dilute the blood of the animal to be tested, so that the blood of the animal to be tested is diluted During the test, the blood of different kinds of animals is diluted with the corresponding dose of diluent to dilute the blood of the tested animal.
- the dosage of the diluent By controlling the dosage of the diluent, the accuracy of the test results of lymphocytes and other white blood cells is improved.
- FIG. 1 is a schematic diagram of the architecture of an optional animal blood cell analyzer provided by an embodiment of the present invention
- FIG. 2 is a schematic diagram of the principle of the impedance method counting test provided by an embodiment of the present invention
- FIG. 3 is a schematic diagram of white blood cell curve distribution provided by an embodiment of the present invention.
- Figure 4 is a schematic flow chart of an optional animal blood cell analysis method provided by an embodiment of the present invention.
- FIG. 5 is a schematic diagram of the architecture of an optional animal blood cell analyzer provided by an embodiment of the present invention.
- Fig. 6 is a schematic flow chart of an optional animal blood cell analysis method provided by an embodiment of the present invention.
- the animal blood cell analyzer selects a target measurement mode from a plurality of animal measurement modes, and determines the target dose of the diluent according to the target measurement mode; and changes the target dose of the diluent Mixing with the blood of the animal to be tested and performing hemolysis treatment to obtain a test sample; and testing the test sample to obtain white blood cell count and classification results.
- the animal blood cell analyzer 100 includes: a sampling needle assembly 101, a mode selection module 102, and a reagent delivery assembly 103.
- the first counting pool component 104 may include a sampling needle and a syringe, which are used to draw blood from the animal to be tested and pump the drawn animal blood into the first counting cell assembly;
- the mode selection module 102 is processed by the animal blood cell analyzer The device is used to determine the current animal measurement mode.
- the reagent delivery component 103 is used to control the amount and time of reagents such as diluent and hemolytic agent entering the first counting cell component of the animal blood cell analyzer, and may include a syringe and a liquid path, wherein the liquid path is set to store the diluent and hemolysis Between the storage place for reagents and the first counting cell assembly, it is used to transfer reagents such as diluents and hemolytic reagents.
- the first counting cell component 104 can perform white blood cell classification and counting tests on blood samples of different types of animals in the first counting cell component.
- the blood sample includes white blood cells, red blood cells, platelets, etc., which can be obtained by processing whole blood drawn from animals with diluents, hemolytic agents, and the like.
- the diluent is an isotonic liquid with appropriate ionic strength and conductivity with acid-base buffering effect.
- the diluent contains hypoxanthine or xanthine compounds or their salts as the main component, or can also be other capable
- the role of hemolytic agents is to dissolve red blood cells for classification and counting of white blood cells.
- the hemolytic agent includes a surfactant, and specifically, it may include a cationic surfactant and a nonionic surfactant.
- the amount and concentration of the hemolytic agent can be selected reasonably according to the actual sample preparation requirements, and it is not specifically limited here.
- the hemolytic agent may contain a quaternary ammonium salt ion surfactant as a main component, or may also be any other surfactant capable of performing the above-mentioned functions.
- the sampling needle sends the blood of the animal to be tested into the first counting cell component, and the reagent delivery component adds the diluent and the hemolytic agent to the first counting cell component to obtain a blood sample, that is, the test sample.
- the first counting cell component counts the first
- the test sample in the pool assembly is the blood sample for testing.
- the counting and classification of white blood cells can include three classifications, four classifications and five classifications. Taking the three classifications as an example, it means that white blood cells are divided into three major types, which are divided into small cell groups (cell groups composed of lymphocytes (Lymphocytes)) and intermediate cell groups (monocytes (Monocytes) through a certain dilution. The number of lymphocytes, monocytes and granulocytes in the blood sample is obtained. In the five classification, leukocytes can be directly classified into neutrophils, lymphocytes, eosinophils, basophils, and monocytes by means of a certain dilution and chemical staining or impedance method.
- the first counting cell component can perform a white blood cell test on an animal blood sample through an impedance method counting test.
- the method of the first counting cell component performing impedance counting test on the detection sample in the first counting cell component may be as follows: the sampling needle draws a quantitative amount of animal blood to be tested from the blood sample, and injects it into the first counting cell component and The quantitative diluent is mixed uniformly to form a diluted test solution with a certain dilution ratio, the hemolytic agent is added, and after mixing, the impedance method counting test is performed in the first counting cell assembly to obtain the white blood cell channel counting result.
- the test sample is obtained by diluting in the front pool of the first counting cell component, and then under the action of negative pressure, from the front cell to the back cell of the first counting cell component through the detection hole.
- the diluted sample flows from the front pool to the back pool to form a stable flow field. Since a constant current source is added between the positive electrode and the negative electrode, a stable electric field is formed, as shown in Figure 2.
- a pulse signal is formed, and particles are divided and counted by the pulse signal.
- FIG. 3 is a schematic diagram of the three classifications of white blood cells, GOHST is red blood cell fragments, LYM is lymphocytes, MON is monocytes, and GRAN is neutrophils.
- the first counting cell component does not impose any limitation on the number of classifications of the white blood cell classification of the test sample.
- the embodiments of the present invention are not limited to the methods and hardware provided, and there may be multiple implementation manners, such as providing a storage medium (stored with programs or instructions for executing the animal blood cell analysis method provided by the embodiments of the present invention).
- Fig. 4 is a schematic diagram of the implementation process of an animal blood cell analysis method provided by an embodiment of the present invention, as shown in Fig. 4, including:
- S401 Select a target measurement mode from multiple animal measurement modes, and determine a target dose of the diluent according to the target measurement mode.
- the mode selection module in the animal blood cell analyzer provides a variety of animal measurement modes, such as: rat measurement mode, cat measurement mode, dog measurement mode, etc., for example, animal measurement mode 1, animal measurement mode 2, etc.
- one type of animal measurement mode corresponds to one type of animal.
- the animal type corresponding to the rat measurement mode is rat
- the animal type corresponding to the cat measurement mode is cat
- the animal type corresponding to the dog measurement mode is dog.
- one animal measurement mode corresponds to multiple types of animals.
- the animal types corresponding to the animal measurement mode 1 include rats and cats
- the animal types corresponding to the animal measurement mode 2 include dogs.
- An animal measurement mode has a corresponding dose of diluent.
- the dosage of the diluent corresponding to different animal measurement modes can be the same or different, that is, the dosage of the diluent corresponding to different types of animals can be the same or different.
- animal types with the same dosage of the corresponding diluent can correspond to the same animal measurement mode, and animal types with different dosages of the corresponding diluent correspond to different animal measurement modes.
- animal types include: type A, type B, type C, and type D.
- the dose of the diluent corresponding to category A and C is dose 1
- the dose of the diluent corresponding to category B is dose 2
- the dose of the diluent corresponding to category D is dose 3
- the animals corresponding to category A and category C The measurement mode is animal measurement mode a
- the animal measurement mode corresponding to category B is animal measurement mode b
- the animal measurement mode corresponding to category D is animal measurement mode c
- the dose of the diluent corresponding to animal measurement mode a is dose 1
- animal The dose of diluent corresponding to measurement mode b is dose 2
- the dose of diluent corresponding to animal measurement mode c is dose 3.
- the mode selection module in the animal blood cell analyzer determines the animal measurement mode corresponding to the blood of the animal to be tested based on the user's operation or the scanning of the scanner in the animal blood cell analyzer, and uses the determined dose of the diluent corresponding to the animal measurement mode as The current target dose is used to determine the current dose of the diluent that needs to be injected into the first counting cell assembly.
- S402 Mix the target-dose diluent with the blood of the animal to be tested and perform hemolysis treatment to obtain a test sample.
- the mode selection module in the animal blood cell analyzer determines the target dose of the diluent, it sends the determined target calculation to the reagent delivery component, and the reagent delivery component mixes the target dose of the diluent with the animal's blood to be tested and performs Hemolysis treatment to obtain test samples.
- the sampling needle assembly is used to suck the blood of the animal to be tested and send it to the first counting cell assembly.
- the reagent delivery component mixes the hemolytic agent with the blood of the animal to be tested to perform hemolysis treatment on the blood of the animal to be tested, dissolve red blood cells in the blood of the animal to be tested, and retain white blood cells in the blood of the animal to be tested.
- the sampling needle assembly sends the blood of the animal to be tested into the first counting cell assembly, and the reagent delivery assembly adds the target dose of diluent and hemolytic agent to the first counting cell assembly, and dilutes the blood of the animal to be tested in the first counting cell assembly And hemolysis treatment to obtain test samples.
- the reagent delivery component adds the target dose of diluent to the first counting cell component at one time; optionally, the reagent delivery component adds the target dose of diluent to the first counting cell component in batches.
- the animal blood cell analyzer is provided with a diluent storage area for storing diluents and a hemolytic agent storage area for storing hemolytic agents.
- the diluent storage area and the hemolytic agent storage area are respectively provided with a first counting cell assembly connected to the The liquid path, the reagent delivery component controls the inflow and stop of the inflow and stop of the diluent in the diluent storage area and the hemolyzing agent in the hemolytic agent storage area into the first counting cell component by controlling the opening and closing of the corresponding liquid path.
- the animal blood cell analyzer is provided with a sampling needle that draws a certain amount of blood from the animal to be tested from a test tube containing the blood of the animal to be tested.
- the sampling needle is controlled by the syringe, it is removed from the animal to be tested.
- the sampling needle is moved to the detection area where the first counting cell assembly is located, and the syringe pumps the blood of the animal to be tested in the sampling needle into the first counting cell assembly, thereby removing the blood from the animal to be tested.
- the blood of the test animal is added to the first counting pool assembly.
- the sampling needle can be moved to the top of the first counting cell assembly first.
- the sampling needle Before the syringe pumps the blood of the animal to be tested in the sampling needle into the first counting cell assembly, the sampling needle can extend vertically from above the first counting cell assembly. Move to the pool of the first counting cell assembly, and the syringe will inject the blood of the animal to be tested in the sampling needle in the pool into the first counting cell assembly, so as to prevent the blood of the animal to be tested in the sampling needle from splashing out of the first counting cell assembly .
- the amount of animal sample to be tested sucked by the sampling needle can be the same or different.
- the same animal blood cell analyzer the sampling needle draws the same dose of the animal sample from the test tube, that is to say, the dose of the animal’s blood to be tested added to the first counting cell assembly is the same, so It is convenient to compare the test results of different kinds of animals.
- the reagent delivery component may include one or more syringes, and the syringe used to add the diluent and hemolytic agent to the first counting cell component may be one syringe or different syringes.
- the reagent delivery component includes a syringe through which the diluent and the hemolytic agent are respectively added to the first counting cell component.
- the reagent delivery component includes a first syringe and a second syringe, and the first syringe is used to add the diluent to the first counting cell component.
- the second syringe is used to add the hemolytic agent to the first counting cell assembly.
- the sampling needle assembly sends the blood of the animal to be tested into the first counting cell assembly and the sequence of adding the diluent and hemolytic agent to the first counting cell assembly by the reagent delivery assembly is not limited.
- the sampling needle assembly and the reagent delivery assembly sequentially add diluent, animal blood and hemolytic agent to the first counting cell assembly.
- the sampling needle assembly and the reagent delivery assembly sequentially add diluent, hemolytic agent and animal blood to be tested into the first counting cell assembly.
- the sampling needle assembly and the reagent delivery assembly simultaneously add the diluent and the animal blood to be tested into the first counting cell assembly, and after adding the diluent and the animal blood to be tested, the reagent delivery assembly adds hemolysis to the first counting cell assembly Agent.
- the diluent is added while adding the blood of the animal to be tested, and the sampling needle that draws the blood of the animal to be tested is cleaned by the diluent, so as to ensure that all the blood of the animal to be tested can be added to the sample needle.
- a counting cell assembly is used.
- the reagent delivery component of the animal blood cell analyzer empties the first counting cell component before mixing the diluent of the target dose with the blood of the animal to be tested and performing hemolysis treatment, so that the first counting The liquid in the pool assembly is cleaned up to avoid the influence of the remaining liquid in the first counting pool assembly on the test results of this test.
- the reagent delivery component of the animal blood cell analyzer mixes the diluent of the target dose with the blood of the animal to be tested and performs hemolysis.
- the first counting cell component includes the diluent
- the When testing at least two of animal blood and hemolytic agent mix the liquid in the first counting cell assembly to fully react the diluent with the blood of the animal to be tested, the hemolytic agent and the blood of the animal to be tested, and ensure the test result Accuracy.
- the dosage of the hemolytic agent added by the reagent delivery assembly to the first counting cell assembly can be adjusted according to the animal measurement mode, and the time of hemolysis treatment, that is, the reaction time between the hemolytic agent and the blood of the animal to be tested, can also be adjusted according to the animal The measurement mode is adjusted.
- the sampling needle assembly sends the blood of the animal to be tested into the first counting cell assembly, and the reagent delivery assembly adds the target dose of diluent and hemolytic agent to the first counting cell assembly to obtain the diluted and hemolyzed test sample, and analyze the animal blood cells
- the test result in the instrument tests the test sample in the first counting cell component to obtain the white blood cell count and classification result.
- the animal blood cell analyzer triggers the first counting cell component to test the test sample based on the user's operation.
- the animal blood cell analyzer automatically triggers the first counting cell component to test the test sample.
- the animal blood cell analyzer automatically triggers the test of the test sample by the first counting cell component based on the reaction time of the hemolytic agent and the blood of the animal to be tested.
- the first counting cell component After the first counting cell component obtains the white blood cell count and classification results, it can send the white blood cell count and classification results to the display of the animal blood cell analyzer, and present it to the inspector through the display of the animal blood cell analyzer, and can also display the white blood cell count and classification results.
- the classification results are sent to the display of other equipment other than the animal blood cell analyzer, and presented to the inspector through the display of other equipment.
- the animal blood cell analyzer and other equipment can be connected via wired or wireless methods.
- the target dose of the diluent used to dilute the animal’s blood is determined based on the animal measurement mode corresponding to the animal species, so that the target dose of the diluent is used to dilute the blood of the animal to be tested, so that the blood of the animal to be tested is diluted During the test, the blood of different types of animals is diluted with the corresponding dose of diluent to dilute the blood of the animal to be tested. By controlling the dosage of the diluent, the accuracy of the test results of lymphocytes and other white blood cells is improved.
- the dilution and hemolysis treatment of the blood of the animal to be tested can be adjusted by adjusting the dosage of the diluent, the dosage of the hemolytic agent, and the reaction time of the hemolytic agent with the blood of the animal to be tested. Improve the accuracy of white blood cell classification and counting results of various animal blood.
- the animal blood cell analyzer provided by the embodiment of the present invention may also include a display 105 and an input device 106 as shown in FIG. 5.
- the display 105 is used to display a software interface
- the input device 106 includes a keyboard or a mouse for the user to input information or instructions.
- the display 105 and the input device 106 may be integrated as a touch display, which can receive information or instructions input by the user while displaying the software interface.
- S401 selects a target measurement mode from a variety of animal measurement modes, including: outputting an animal measurement mode selection interface; receiving an animal in the measurement mode selection interface The input operation or the selection operation of the measurement mode; the target measurement mode is determined from a plurality of animal measurement modes according to the input operation or the selection operation.
- the display 105 is used to output the animal measurement mode selection interface; the input device 106 is used to receive input operations or selection operations for the animal measurement mode in the measurement mode selection interface; the mode selection module 102 is used to The input operation or the selection operation determines the target measurement mode from a plurality of animal measurement modes.
- the display can output an animal measurement mode selection interface for selecting an animal measurement mode.
- an animal measurement mode a variety of animal measurement modes or animal types can be displayed, so that the user can input the current animal measurement mode through the input device based on the animal measurement mode selection interface.
- Type or target measurement mode When the information input by the user is the type of animal, the mode selection module can determine the animal measurement mode corresponding to the input animal type from multiple animal measurement modes as the target measurement mode.
- the input device can receive the user's input operation or selection operation.
- an input interface may be provided in the animal measurement mode selection interface, and the animal type or target measurement mode input by the user is received through the input interface.
- a variety of animal types or animal measurement modes can be provided in the animal measurement mode selection interface, and the animal type or target measurement mode selected by the user is determined.
- the animal blood cell analyzer provided by the embodiment of the present invention may also include a scanner 107 as shown in FIG. 5.
- the scanner 107 is used to scan information identifiers such as barcodes and two-dimensional codes to obtain the information carried by the information identifiers.
- selecting a target measurement mode from a variety of animal measurement modes including: scanning the information identifier on the test tube containing the blood of the animal to be tested to obtain the Sample information of the blood of the animal to be tested; according to the sample information, a target measurement mode is selected from a variety of animal measurement modes.
- the scanner 107 is used to scan the information identifier on the test tube containing the blood of the animal to be tested to obtain sample information of the blood of the animal to be tested;
- the mode selection module 102 is used to, according to the sample information, Select the target measurement mode from a variety of animal measurement modes.
- the test tube containing the blood of the animal to be tested is affixed with a label, and the label contains a barcode, two-dimensional code and other information identifiers that carry the information of the animal’s blood to be tested.
- the information carried by the information identifier may include: the blood of the animal to be tested belongs to The type of animal, the Universally Unique Identifier (UUID) of the animal's blood to be tested, and the test item is waiting to test the blood sample information of the animal.
- UUID Universally Unique Identifier
- the sample information carried by the information identifier is not limited in any way.
- the scanner scans the information mark on the test tube to obtain the sample information of the blood of the animal to be tested carried by the information mark, and then scan the scanned animal to be tested
- the blood sample information is sent to the mode selection module, and the mode selection module determines the animal measurement mode corresponding to the animal blood in the test tube according to the sample information related to the animal type or the animal measurement mode in the sample information scanned by the scanner, that is, the target measurement mode .
- the mode selection module determines that the target measurement mode is a cat measurement mode.
- the sample information scanned by the scanner includes the animal species to which the blood of the animal to be tested belongs, and the animal species is cat, then the model selection module determines that the target measurement mode is the cat measurement mode.
- the sample information scanned by the scanner includes the UUID, which is the sample ID of the blood of the animal to be tested, and the sample ID is 1111.
- the mode selection module determines that the animal measurement mode corresponding to the blood of the animal to be tested is the cat measurement mode according to the sample ID 1111. ,
- the target measurement mode is determined to be the cat measurement mode.
- the method of adding the diluent, the blood of the animal to be tested, and the hemolytic agent to the first counting cell assembly can include:
- S402 mixes the diluent of the target dose with the blood of the animal to be tested and performs hemolysis treatment to obtain a test sample, including: adding the diluent of the target dose to the first counting cell assembly; The hemolytic agent and the blood of the animal to be tested are added to the first counting cell component to obtain a test sample.
- the sampling needle assembly sends the blood of the animal to be tested into the first counting pool assembly, and the reagent delivery assembly adds a target dose of diluent to the first counting pool assembly; and adds to the first counting pool assembly Hemolytic agent.
- the reagent delivery component When the reagent delivery component adds the diluent to the first counting cell component, it directly adds the target dose of diluent to the first counting cell component, and after adding the target dose of diluent, adds and hemolyzes to the first counting cell component Agent.
- the sampling needle can send the blood of the animal to be tested into the first counting cell component during or after the reagent delivery component adds the diluent to the first counting cell component.
- the reagent delivery component adds the target dose of diluent to the first counting cell component, and after the reagent delivery component adds the target dose of diluent, the sampling needle component adds the blood of the animal to be tested to the first counting cell component, and then the sample After the needle assembly is added to the blood of the animal to be tested, the reagent delivery assembly continues to add the hemolytic agent to the first counting cell assembly.
- the reagent delivery component adds the target dose of diluent to the first counting cell component
- the sampling needle component adds the blood of the animal to be tested into the first counting cell component
- the sampling needle component adds the first counting cell component to the first counting cell component. After the blood of the animal to be tested, the reagent delivery component continues to add the hemolytic agent to the first counting cell component.
- the process of adding the diluent is uninterrupted, but the order of adding the diluent, hemolytic agent, and animal blood to be tested is not limited in any way.
- S402 mixing the target dose of diluent with the blood of the animal to be tested and performing hemolysis treatment includes: adding the blood of the animal to be tested to the first dose of diluent to obtain a reference test sample; A second dose of diluent and hemolytic agent are added to the reference test sample to obtain the test sample, and the sum of the first dose and the second dose is the target dose.
- the reagent delivery component adds a first dose of diluent to the first counting cell before or while the sampling needle component sends the blood of the animal to be tested into the first counting cell; And after adding the blood of the animal to be tested into the first counting cell component, a second dose of diluent and the hemolytic agent are added to the first counting cell component.
- the reagent delivery component first adds the first dose of diluent to the first counting cell component, and the sampling needle component adds the blood of the animal to be tested to the first counting cell component, and the animal to be tested is added to the first counting cell component in the sampling needle component. After the blood, the reagent delivery component continues to add the second dose of diluent to the first counting cell component, and adds the hemolytic agent, so that the first dose of diluent is added to the first counting cell component, and then to the first counting cell Add a second dose of diluent to the assembly.
- the reagent delivery component adding the first dose of diluent to the first counting cell component can be executed before the sampling needle component adds the blood of the animal to be tested to the first counting cell component, or it can be combined with the sampling needle component to the first counting. Adding the blood of the animal to be tested into the pool assembly is performed at the same time.
- the size of the first dose may be the same or different.
- the animal blood cell analyzer draws a fixed dose of the reference test sample from the reference test sample before adding the second dose of diluent and hemolytic agent to the reference test sample;
- the fixed dose of the reference test sample is subjected to red blood cell test and/or platelet test.
- the sampling needle assembly in the animal blood cell analyzer draws a fixed dose of a reference test sample composed of the first dose of diluent and the animal blood to be tested from the first counting cell assembly; the first The second counting cell component performs red blood cell test and/or platelet test on the reference test sample of the fixed dose.
- the second counting cell component is a different counting cell component from the first counting cell component.
- the second counting cell component and the first counting cell component belong to the same animal blood cell analyzer.
- the second counting cell component and the first counting cell component belong to different animal blood cell analyzers.
- the first counting cell component Before adding the hemolytic agent to the first counting cell component to form a test sample, the first counting cell component only includes the first dose of diluent and the animal's blood to be tested, that is, the first counting cell component is for diluting the blood of the animal to be tested
- the reference test sample can be drawn from the first counting cell assembly by the sampling needle assembly, and the second counting cell assembly can perform at least one of the following red blood cell-related tests on the reference test sample drawn by the sampling needle: Red blood cell test and platelet test.
- the dose of the reference test sample drawn by the sampling needle assembly from the first counting cell assembly can be 9uL, 11uL, and so on.
- the size of the fixed dose can be set according to actual needs, which is not limited in the embodiment of the present invention.
- the first dose is the same.
- the reference test sample has the same dose of the animal sample to be tested, and the same diluent dose, the dilution ratio of the reference test sample corresponding to different animal species is the same, so It is convenient to compare the red blood cell test or platelet test results of different animal species.
- the second addition method based on whether the first dose of diluent is added to the first counting cell assembly at one time, the second addition method can include the following two situations:
- adding the blood of the animal to be tested to the first dose of diluent to obtain a reference test sample includes: adding the first dose of diluent to the first counting cell assembly; The blood of the animal to be tested is added to the counting pool assembly to obtain a reference test sample.
- the reagent delivery component adds the first dose of diluent to the first counting cell component before the sampling needle component sends the blood of the animal to be tested into the first counting cell component.
- adding the blood of the animal to be tested to the first dose of diluent to obtain a reference test sample includes: adding a third dose of diluent to the first counting cell assembly; A fourth dose of diluent and the blood of the animal to be tested are added to the counting cell assembly to obtain a reference test sample, and the sum of the third dose and the fourth dose is the first dose.
- the reagent delivery component adds a third dose of diluent to the first counting cell component to the first counting cell component before the sampling needle component sends the blood of the animal to be tested into the first counting cell component; and
- a fourth dose of diluent and the blood of the animal to be tested are added to the first counting pool assembly.
- Case 1 and Case 2 are examples of adding the diluent of the target dose to the first counting cell assembly in two and three times. In practical applications, the diluent of the target dose is added to the first counting cell assembly. The number of times of adding in batches, and the order of adding the same hemolytic agent and blood to be tested can be controlled according to actual needs.
- the reagent delivery assembly and the sampling needle assembly can simultaneously add a fourth dose of diluent and the blood of the animal to be tested into the first counting cell assembly, and the blood of the animal to be tested on the sampling needle is washed by the added diluent to ensure The blood of the animal to be tested can all be added to the first counting pool component to ensure the accuracy of classification and counting results.
- the operator can flexibly set the target dose of diluent adding process according to actual needs. For example, when adding the target dose of diluent, first add the first counting cell assembly to the first counting cell assembly. Dose of diluent and animal blood to be tested, and then add a second dose of diluent and hemolytic agent to the first counting cell assembly, so that in the process of forming the test sample, a reference test sample can be obtained, which can be used for white blood cell testing at the same time , Carry out red blood cell test, platelet test and other tests related to red blood cells.
- the sampling needle assembly sucks blood of the animal to be tested.
- the sampling needle assembly draws a specified dose of animal blood to be tested from the test tube.
- the first counting pool component is emptied.
- the reagent delivery component adds a first dose of diluent to the first counting cell component.
- the syringe in the reagent delivery assembly opens the liquid path between the first counting cell assembly and the diluent storage position, adds the diluent to the first counting cell assembly through the opened liquid path, and after adding the first dose of diluent, the The opened hydraulic circuit is closed. During this process, the liquid path between the first counting cell component and the hemolytic agent storage position is in a closed state.
- sampling needle assembly adds blood of the animal to be tested into the first counting cell assembly.
- the syringe in the sampling needle assembly controls the sampling needle to move from the sampling area for sucking the blood of the animal to be tested from the test tube to above the first counting cell assembly in the detection area for detecting the blood sample, and from the first counting cell
- the upper part of the assembly moves into the pool of the first counting cell assembly, and the syringe in the sampling needle assembly injects the blood of the animal to be tested in the sampling needle in the first counting cell assembly into the first counting cell assembly.
- the sampling needle assembly draws a reference test sample from the first counting cell assembly to perform red blood cell test and platelet test.
- the reagent delivery component adds a hemolytic agent to the first counting cell component.
- the syringe in the reagent delivery assembly opens the liquid path between the first counting cell assembly and the hemolytic agent storage position, and adds the hemolytic agent to the first counting cell assembly through the opened liquid path. After adding the hemolytic agent, the opened liquid path is opened shut down. During this process, the liquid path between the first counting cell component and the diluent storage position is in a closed state.
- the reagent delivery component adds a second dose of diluent to the first counting cell component.
- the first counting cell component tests the reference sample in the first counting cell component to obtain white blood cell count and classification results.
- the animal blood cell analysis method provided by the embodiment of the present invention uses different diluent dosages between different animal species when performing white blood cell channel test between different animal species, combined with adjusting the hemolysis dose and hemolysis time, so as to ensure the accuracy of the white blood cell count test result. Under the premise of sex, provide the accuracy of lymphocyte test results.
- the percentage of lymphocytes in the blood sample of the mouse is 65%.
- the blood sample is microscopically examined, and the percentage of lymphocytes in the microscopic examination result is 75%.
- the result of the microscopic examination is There is a 10% difference from the actual measurement result.
- we will find that it is not a sample almost all samples have the same problem.
- the animal blood cell analysis method provided by the embodiment of the present invention can further improve the accuracy of the lymphocyte test result by changing the amount of the diluent.
- test results of the animal blood cell analysis method provided in the embodiment of the present invention will be described through the count results of lymphocytes in blood samples of different types of animals.
- the amount of blood collected in this embodiment can be 9ul. Before adjustment, all measurement modes correspond to 2.4ml diluent. Table 1 collected the blood of 7 horses to form the blood of 7 animals to be tested, and set the adjusted diluent volume to 1.4ml. The percentage of lymphocytes before the diluent volume was adjusted, and the diluent volume after the diluent volume was adjusted. The percentage of lymphocytes and the percentage of lymphocytes in the microscopic examination results are compared.
- mice The blood of 7 mice was collected to form 7 animal blood to be tested, and the adjusted dilution volume was set to 1.6ml, the percentage of lymphocytes before the adjustment of the dilution volume, and the adjustment of the dilution volume The percentage of lymphocytes and the percentage of lymphocytes in the microscopic examination results are compared. Among them, Lym% represents the percentage of lymphocytes.
- the embodiment of the present invention further provides a storage medium, that is, a computer-readable storage medium, and an executable program is stored on the storage medium.
- the executable program is executed by a processor
- the animal blood cell analyzer can be executed by the animal blood cell analyzer. Steps of blood cell analysis method.
- the above animal blood cell analysis method is implemented in the form of a software functional module and sold or used as an independent product, it can also be stored in a computer readable storage medium.
- the computer software product is stored in a storage medium and includes several instructions for A computer device (which may be a personal computer, a server, or a network device, etc.) executes all or part of the methods described in the various embodiments of the present invention.
- the aforementioned storage media include: U disk, mobile hard disk, Read Only Memory (ROM, Read Only Memory), magnetic disk or optical disk and other media that can store program codes. In this way, the embodiments of the present invention are not limited to any specific combination of hardware and software.
- the disclosed device and method may be implemented in other ways.
- the device embodiments described above are merely illustrative.
- the division of the units is only a logical function division, and there may be other divisions in actual implementation, such as: multiple units or components can be combined, or It can be integrated into another system, or some features can be ignored or not implemented.
- the coupling, or direct coupling, or communication connection between the components shown or discussed may be indirect coupling or communication connection through some interfaces, devices or units, and may be in electrical, mechanical or other forms. of.
- the units described above as separate components may or may not be physically separate, and the components displayed as units may or may not be physical units; they may be located in one place or distributed on multiple network units; Some or all of the units may be selected according to actual needs to achieve the purpose of the solution of the embodiment.
- the functional units in the embodiments of the present invention can be all integrated into one processing unit, or each unit can be individually used as a unit, or two or more units can be integrated into one unit; the above-mentioned integration
- the unit can be implemented in the form of hardware, or in the form of hardware plus software functional units.
- the foregoing program can be stored in a computer readable storage medium.
- the execution includes The steps of the foregoing method embodiment; and the foregoing storage medium includes: various media that can store program codes, such as a removable storage device, a read only memory (Read Only Memory, ROM), a magnetic disk, or an optical disk.
- ROM Read Only Memory
- the aforementioned integrated unit of the present invention is implemented in the form of a software function module and sold or used as an independent product, it can also be stored in a computer readable storage medium.
- the computer software product is stored in a storage medium and includes several instructions for A computer device (which may be a personal computer, a server, or a network device, etc.) executes all or part of the methods described in the various embodiments of the present invention.
- the aforementioned storage media include: removable storage devices, ROMs, magnetic disks or optical discs and other media that can store program codes.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Ecology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Disclosed is a method for the analysis of animal blood cells, applied to an animal blood cell analyzer (100). The method comprises: selecting a target measurement mode from various animal measurement modes, and determining a target dose of diluent according to the target measurement mode (401); mixing the target dose of diluent with the blood of an animal to be tested and performing a hemolysis treatment to obtain a detection sample (402); and testing the detection sample to obtain a white blood cell count and classification results (403). Also disclosed is an animal blood cell analyzer (100) and a storage medium.
Description
本发明实施例涉及动物血液细胞分析技术,涉及但不限于一种动物血液细胞分析方法、分析仪及存储介质。The embodiment of the present invention relates to animal blood cell analysis technology, and relates to but is not limited to an animal blood cell analysis method, analyzer and storage medium.
动物血液细胞分析的主要原理是对稀释后的动物血液样本通过微孔进行白细胞、红细胞和血小板等参数的测试。The main principle of animal blood cell analysis is to test the parameters of white blood cells, red blood cells and platelets on the diluted animal blood samples through micropores.
在一台动物血液细胞分析仪上,需要对狗、猫、大鼠、小鼠、兔等多种动物的血液样本进行测试,但是,每种动物的白细胞通道的溶血过程是不一样的。因此,相关技术中,在一台动物血液细胞分析仪上,无法保证白细胞计数和分类结果的准确性。On an animal blood cell analyzer, blood samples of dogs, cats, rats, mice, rabbits and other animals need to be tested. However, the hemolysis process of the white blood cell channel of each animal is different. Therefore, in related technologies, an animal blood cell analyzer cannot guarantee the accuracy of the white blood cell count and classification results.
发明内容Summary of the invention
本发明实施例提供了一种动物血液细胞分析方法、分析仪及存储介质,提高不同种类动物的白细胞计数和分类结果的准确性。The embodiment of the present invention provides an animal blood cell analysis method, analyzer and storage medium to improve the accuracy of white blood cell count and classification results of different types of animals.
本发明实施例提供一种动物血液细胞分析方法,应用于动物血液细胞分析仪,所述方法包括:The embodiment of the present invention provides an animal blood cell analysis method, which is applied to an animal blood cell analyzer, and the method includes:
从多种动物测量模式中选中目标测量模式,并根据所述目标测量模式确定稀释液的目标剂量;Select a target measurement mode from a variety of animal measurement modes, and determine the target dose of the diluent according to the target measurement mode;
将所述目标剂量的稀释液与待测动物血液进行混合并进行溶血处理,得到检测样本;Mixing the diluent of the target dose with the blood of the animal to be tested and performing hemolysis treatment to obtain a test sample;
对所述检测样本进行测试,得到白细胞计数和分类结果。The test sample is tested to obtain white blood cell count and classification results.
本发明实施例提供一种动物血液细胞分析仪,所述动物血液细胞分析仪,包括:The embodiment of the present invention provides an animal blood cell analyzer. The animal blood cell analyzer includes:
采样针组件,用于吸取待测动物血液并送至第一计数池组件;The sampling needle assembly is used to suck the blood of the animal to be tested and send it to the first counting cell assembly;
模式选择模块,用于从多种动物测量模式中选中目标测量模式,并根据所述目标测量模式确定稀释液的目标剂量;The mode selection module is used to select a target measurement mode from a variety of animal measurement modes, and determine the target dose of the diluent according to the target measurement mode;
试剂输送组件,用于将所述目标剂量的稀释液与所述待测动物血液进行混合,并进行溶血处理,得到检测样本;A reagent delivery component, which is used to mix the diluent of the target dose with the blood of the animal to be tested, and perform hemolysis treatment to obtain a test sample;
第一计数池组件,用于对所述检测样本进行测试,得到白细胞计数和分类结果。The first counting cell component is used to test the test sample to obtain the white blood cell count and classification results.
本发明实施例提供一种存储介质,所述存储介质上存储有可执行程序,所述可执行程序被处理器执行时,实现上述动物血液细胞分析仪执行的动物血液细胞分析方法的步骤。An embodiment of the present invention provides a storage medium with an executable program stored on the storage medium, and when the executable program is executed by a processor, the steps of the animal blood cell analysis method executed by the animal blood cell analyzer are implemented.
本发明实施例中,基于动物种类对应的动物测量模式确定用于对动物血液进行稀释的稀释液的目标剂量,以通过目标剂量的稀释液对待测动物血液进行稀释,从而在对待测动物血液进行测试时,对不同种类的动物的血液,使用对应剂量的稀释液对待测动物血液进行稀释,通过控制稀释液的剂量,提高淋巴细胞等白细胞的测试结果的准确性。In the embodiment of the present invention, the target dose of the diluent used to dilute the animal’s blood is determined based on the animal measurement mode corresponding to the animal species, so that the target dose of the diluent is used to dilute the blood of the animal to be tested, so that the blood of the animal to be tested is diluted During the test, the blood of different kinds of animals is diluted with the corresponding dose of diluent to dilute the blood of the tested animal. By controlling the dosage of the diluent, the accuracy of the test results of lymphocytes and other white blood cells is improved.
图1为本发明实施例提供的可选的动物血液细胞分析仪架构示意图;FIG. 1 is a schematic diagram of the architecture of an optional animal blood cell analyzer provided by an embodiment of the present invention;
图2为本发明实施例提供的阻抗法计数测试的原理示意图;FIG. 2 is a schematic diagram of the principle of the impedance method counting test provided by an embodiment of the present invention;
图3为本发明实施例提供的白细胞曲线分布示意图;3 is a schematic diagram of white blood cell curve distribution provided by an embodiment of the present invention;
图4为本发明实施例提供的可选的动物血液细胞分析方法的流程示意图;Figure 4 is a schematic flow chart of an optional animal blood cell analysis method provided by an embodiment of the present invention;
图5为本发明实施例提供的可选的动物血液细胞分析仪架构示意图;5 is a schematic diagram of the architecture of an optional animal blood cell analyzer provided by an embodiment of the present invention;
图6为本发明实施例提供的可选的动物血液细胞分析方法的流程示意图。Fig. 6 is a schematic flow chart of an optional animal blood cell analysis method provided by an embodiment of the present invention.
以下结合附图及实施例,对本发明进行进一步详细说明。应当理解, 此处所提供的实施例仅仅用以解释本发明,并不用于限定本发明。另外,以下所提供的实施例是用于实施本发明的部分实施例,而非提供实施本发明的全部实施例,在不冲突的情况下,本发明实施例记载的技术方案可以任意组合的方式实施。The present invention will be further described in detail below in conjunction with the drawings and embodiments. It should be understood that the embodiments provided here are only used to explain the present invention, but not to limit the present invention. In addition, the embodiments provided below are part of the embodiments for implementing the present invention, rather than providing all the embodiments for implementing the present invention. In the case of no conflict, the technical solutions described in the embodiments of the present invention can be combined in any manner. Implement.
在本发明的各种实施例中:动物血液细胞分析仪从多种动物测量模式中选中目标测量模式,并根据所述目标测量模式确定稀释液的目标剂量;以及将所述目标剂量的稀释液与待测动物血液进行混合并进行溶血处理,得到检测样本;并对所述检测样本进行测试,得到白细胞计数和分类结果。In various embodiments of the present invention: the animal blood cell analyzer selects a target measurement mode from a plurality of animal measurement modes, and determines the target dose of the diluent according to the target measurement mode; and changes the target dose of the diluent Mixing with the blood of the animal to be tested and performing hemolysis treatment to obtain a test sample; and testing the test sample to obtain white blood cell count and classification results.
本发明实施例提供一种动物血液细胞分析方法,该方法应用于动物血液细胞分析仪,如图1所示,动物血液细胞分析仪100包括:采样针组件101、模式选择模块102、试剂输送组件103、第一计数池组件104。其中,采样针组件101可包括采样针和注射器,用于吸取待测动物血液,并将吸取的待测动物血液打入第一计数池组件;模式选择模块102由动物血液细胞分析仪中的处理器实现,用于确定当前的动物测量模式。试剂输送组件103用于控制稀释液、溶血剂等试剂进入动物血液细胞分析仪的第一计数池组件中的量和时间,可包括注射器和液路,其中,液路设置于存放稀释液、溶血剂等存放位与第一计数池组件之间,用于传输稀释液、溶血剂等试剂。第一计数池组件104能够对第一计数池组件中的不同种类动物的血液样本进行白细胞分类和计数测试。The embodiment of the present invention provides an animal blood cell analysis method, which is applied to an animal blood cell analyzer. As shown in FIG. 1, the animal blood cell analyzer 100 includes: a sampling needle assembly 101, a mode selection module 102, and a reagent delivery assembly 103. The first counting pool component 104. Among them, the sampling needle assembly 101 may include a sampling needle and a syringe, which are used to draw blood from the animal to be tested and pump the drawn animal blood into the first counting cell assembly; the mode selection module 102 is processed by the animal blood cell analyzer The device is used to determine the current animal measurement mode. The reagent delivery component 103 is used to control the amount and time of reagents such as diluent and hemolytic agent entering the first counting cell component of the animal blood cell analyzer, and may include a syringe and a liquid path, wherein the liquid path is set to store the diluent and hemolysis Between the storage place for reagents and the first counting cell assembly, it is used to transfer reagents such as diluents and hemolytic reagents. The first counting cell component 104 can perform white blood cell classification and counting tests on blood samples of different types of animals in the first counting cell component.
血液样本中包括白细胞、红细胞和血小板等,其可以通过将动物上抽取的全血经过稀释液、溶血剂等处理后而获得。其中,稀释液是具有酸碱缓冲作用的具有适当的离子强度和电导率的等渗液,例如,稀释液以次黄嘌呤或黄嘌呤类化合物或其盐为主要成分,或者也可以是其他能够起到上述作用的稀释液。溶血剂的作用则是溶解红细胞,以进行白细胞分类与计数。溶血剂包括表面活性剂,其具体而言可以包括阳离子表面活性剂和非 离子表面活性剂。其中,溶血剂的使用量和浓度等可以根据实际的制样要求进行合理选择,在此不对其进行具体限定。溶血剂可以以季铵盐离子表面活性剂为主要成分,或者也可以是其他任意能够起到上述作用的表面活性剂。The blood sample includes white blood cells, red blood cells, platelets, etc., which can be obtained by processing whole blood drawn from animals with diluents, hemolytic agents, and the like. Among them, the diluent is an isotonic liquid with appropriate ionic strength and conductivity with acid-base buffering effect. For example, the diluent contains hypoxanthine or xanthine compounds or their salts as the main component, or can also be other capable The diluent that plays the above-mentioned role. The role of hemolytic agents is to dissolve red blood cells for classification and counting of white blood cells. The hemolytic agent includes a surfactant, and specifically, it may include a cationic surfactant and a nonionic surfactant. Among them, the amount and concentration of the hemolytic agent can be selected reasonably according to the actual sample preparation requirements, and it is not specifically limited here. The hemolytic agent may contain a quaternary ammonium salt ion surfactant as a main component, or may also be any other surfactant capable of performing the above-mentioned functions.
这里,采样针将待测动物血液送入第一计数池组件,且试剂输送组件将稀释液、溶血剂加入第一计数池组件中,得到血样即检测样本,第一计数池组件对第一计数池组件中的检测样本即血样进行检测。Here, the sampling needle sends the blood of the animal to be tested into the first counting cell component, and the reagent delivery component adds the diluent and the hemolytic agent to the first counting cell component to obtain a blood sample, that is, the test sample. The first counting cell component counts the first The test sample in the pool assembly is the blood sample for testing.
白细胞的计数和分类可包括三分类、四分类和五分类。以三分类为例,是指将白细胞分成三大类,是通过一定的稀释液将分别为小细胞群(由淋巴细胞(Lymphocyte)构成的细胞群)、中间细胞群(由单核细胞(Monocyte)构成的细胞群)和大细胞群(由粒细胞(Granulocyte)构成的细群),并得到血样中的淋巴细胞、单核细胞和粒细胞的数量。五分类可以借助一定的稀释及化学染色或者阻抗法的方法将白细胞直接分为中性粒细胞、淋巴细胞、嗜酸性粒细胞、嗜碱性粒细胞、单核细胞。The counting and classification of white blood cells can include three classifications, four classifications and five classifications. Taking the three classifications as an example, it means that white blood cells are divided into three major types, which are divided into small cell groups (cell groups composed of lymphocytes (Lymphocytes)) and intermediate cell groups (monocytes (Monocytes) through a certain dilution. The number of lymphocytes, monocytes and granulocytes in the blood sample is obtained. In the five classification, leukocytes can be directly classified into neutrophils, lymphocytes, eosinophils, basophils, and monocytes by means of a certain dilution and chemical staining or impedance method.
第一计数池组件可通过阻抗法计数测试对动物血样进行白细胞测试。第一计数池组件对第一计数池组件中的检测样本进行阻抗法计数测试的方法的过程可以如下:采样针从血液样本中吸出定量的待测动物血液,注入到第一计数池组件中与定量的稀释液进行混匀,形成具有一定稀释比的稀释试液,加入溶血剂,混匀后在第一计数池组件中进行阻抗法计数测试,进而获得白细胞通道计数结果。其中,首先在第一计数池组件的前池中进行稀释而获得检测样本,然后在负压的作用下,由前池经检测孔到第一计数池组件的后池中。计数过程中,稀释后样本从前池流入到后池中,形成稳定的流场。由于在正电极和负电极之间加上恒流源,故形成稳定的电场,如图2所示。当血细胞通过检测小孔142时会形成脉冲信号,通过脉冲信号进行粒子划分和计数。The first counting cell component can perform a white blood cell test on an animal blood sample through an impedance method counting test. The method of the first counting cell component performing impedance counting test on the detection sample in the first counting cell component may be as follows: the sampling needle draws a quantitative amount of animal blood to be tested from the blood sample, and injects it into the first counting cell component and The quantitative diluent is mixed uniformly to form a diluted test solution with a certain dilution ratio, the hemolytic agent is added, and after mixing, the impedance method counting test is performed in the first counting cell assembly to obtain the white blood cell channel counting result. Wherein, firstly, the test sample is obtained by diluting in the front pool of the first counting cell component, and then under the action of negative pressure, from the front cell to the back cell of the first counting cell component through the detection hole. During the counting process, the diluted sample flows from the front pool to the back pool to form a stable flow field. Since a constant current source is added between the positive electrode and the negative electrode, a stable electric field is formed, as shown in Figure 2. When blood cells pass through the detection hole 142, a pulse signal is formed, and particles are divided and counted by the pulse signal.
根据阻抗法原理,经溶血剂处理后,红细胞破裂,破裂后的红细胞碎片体积不影响白细胞结果的计数,白细胞在溶血剂作用下,体积缩小、不同体积的白细胞通过小孔时,脉冲大小不同,将体积为35~250费升(fl)白细胞。经溶血剂处理后,淋巴细胞在小细胞区;粒细胞在大细胞区,单核细胞在中间细胞区。动物血液细胞分析仪根据各亚群占总量的比例,计算出各亚群细胞的百分率。其中,图3中为白细胞三分类的示意图,GOHST为红细胞碎片,LYM为淋巴细胞,MON为单核细胞,GRAN为中性粒细胞。According to the principle of impedance method, after the hemolytic agent is treated, the red blood cells are ruptured, and the volume of the broken red blood cell fragments does not affect the counting of white blood cells. Under the action of the hemolytic agent, the white blood cells shrink in size and when white blood cells of different volumes pass through the small holes, the pulse size is different. Set the volume to 35-250 Fe liters (fl) of white blood cells. After treatment with hemolytic agent, lymphocytes are in the small cell area; granulocytes are in the large cell area, and monocytes are in the middle cell area. The animal blood cell analyzer calculates the percentage of cells in each subgroup according to the proportion of each subgroup in the total. Among them, Figure 3 is a schematic diagram of the three classifications of white blood cells, GOHST is red blood cell fragments, LYM is lymphocytes, MON is monocytes, and GRAN is neutrophils.
本发明实施例中,第一计数池组件对检测样本进行白细胞分类的分类数量不进行任何的限定。In the embodiment of the present invention, the first counting cell component does not impose any limitation on the number of classifications of the white blood cell classification of the test sample.
当然,本发明实施例不局限于提供为方法和硬件,还可有多种实现方式,例如提供存储介质(存储有用于执行本发明实施例提供的动物血液细胞分析方法的程序或指令)。Of course, the embodiments of the present invention are not limited to the methods and hardware provided, and there may be multiple implementation manners, such as providing a storage medium (stored with programs or instructions for executing the animal blood cell analysis method provided by the embodiments of the present invention).
图4为本发明实施例提供的动物血液细胞分析方法的实现流程示意图,如图4所示,包括:Fig. 4 is a schematic diagram of the implementation process of an animal blood cell analysis method provided by an embodiment of the present invention, as shown in Fig. 4, including:
S401,从多种动物测量模式中选中目标测量模式,并根据所述目标测量模式确定稀释液的目标剂量。S401: Select a target measurement mode from multiple animal measurement modes, and determine a target dose of the diluent according to the target measurement mode.
动物血液细胞分析仪中的模式选择模块提供多种动物测量模式,比如:大鼠测量模式、猫测量模式、狗测量模式等,又比如,动物测量模式1、动物测量模式2等。在一示例中,一种动物测量模式对应一个种类的动物,比如:大鼠测量模式对应的动物种类为大鼠,猫测量模式对应的动物种类为猫、狗测量模式对应的动物种类为狗。在又一示例中,一种动物测量模式对应多种类的动物,比如:动物测量模式1对应的动物种类包括:鼠和猫,动物测量模式2对应的动物种类包括:狗。The mode selection module in the animal blood cell analyzer provides a variety of animal measurement modes, such as: rat measurement mode, cat measurement mode, dog measurement mode, etc., for example, animal measurement mode 1, animal measurement mode 2, etc. In an example, one type of animal measurement mode corresponds to one type of animal. For example, the animal type corresponding to the rat measurement mode is rat, the animal type corresponding to the cat measurement mode is cat, and the animal type corresponding to the dog measurement mode is dog. In another example, one animal measurement mode corresponds to multiple types of animals. For example, the animal types corresponding to the animal measurement mode 1 include rats and cats, and the animal types corresponding to the animal measurement mode 2 include dogs.
一种动物测量模式具有对应剂量的稀释液。其中,不同的动物测量模 式对应的稀释液的剂量可相同,也可不同,也就是说,不同种类动物对应的稀释液的剂量可相同,也可不同。An animal measurement mode has a corresponding dose of diluent. Among them, the dosage of the diluent corresponding to different animal measurement modes can be the same or different, that is, the dosage of the diluent corresponding to different types of animals can be the same or different.
在实际应用中,对应的稀释液的剂量相同的动物种类可对应同一种动物测量模式,对应的稀释液的剂量不同的动物种类对应的不同的动物测量模式。比如:动物种类包括:种类A、种类B、种类C和种类D。其中,种类A和种类C对应的稀释液的剂量为剂量1,种类B对应的稀释液的剂量为剂量2,种类D对应的稀释液的剂量为剂量3,则种类A和种类C对应的动物测量模式为动物测量模式a,种类B对应的动物测量模式为动物测量模式b,种类D对应的动物测量模式为动物测量模式c,且动物测量模式a对应的稀释液的剂量为剂量1,动物测量模式b对应的稀释液的剂量为剂量2,动物测量模式c对应的稀释液的剂量为剂量3。In practical applications, animal types with the same dosage of the corresponding diluent can correspond to the same animal measurement mode, and animal types with different dosages of the corresponding diluent correspond to different animal measurement modes. For example, animal types include: type A, type B, type C, and type D. Among them, the dose of the diluent corresponding to category A and C is dose 1, the dose of the diluent corresponding to category B is dose 2, and the dose of the diluent corresponding to category D is dose 3, then the animals corresponding to category A and category C The measurement mode is animal measurement mode a, the animal measurement mode corresponding to category B is animal measurement mode b, the animal measurement mode corresponding to category D is animal measurement mode c, and the dose of the diluent corresponding to animal measurement mode a is dose 1, animal The dose of diluent corresponding to measurement mode b is dose 2, and the dose of diluent corresponding to animal measurement mode c is dose 3.
动物血液细胞分析仪中的模式选择模块基于用户的操作或动物血液细胞分析仪中扫描器的扫描确定待测动物血液对应的动物测量模式,并将确定的动物测量模式对应的稀释液的剂量作为当前的目标剂量,以确定当前需要打入第一计数池组件中的稀释液的剂量。The mode selection module in the animal blood cell analyzer determines the animal measurement mode corresponding to the blood of the animal to be tested based on the user's operation or the scanning of the scanner in the animal blood cell analyzer, and uses the determined dose of the diluent corresponding to the animal measurement mode as The current target dose is used to determine the current dose of the diluent that needs to be injected into the first counting cell assembly.
S402、将所述目标剂量的稀释液与待测动物血液进行混合并进行溶血处理,得到检测样本。S402: Mix the target-dose diluent with the blood of the animal to be tested and perform hemolysis treatment to obtain a test sample.
动物血液细胞分析仪中的模式选择模块确定稀释液的目标剂量后,将确定的目标计算发送至试剂输送组件,试剂输送组件将所述目标剂量的稀释液与待测动物血液进行混合,并进行溶血处理,得到检测样本。这里,采样针组件,用于吸取待测动物血液并送至第一计数池组件。After the mode selection module in the animal blood cell analyzer determines the target dose of the diluent, it sends the determined target calculation to the reagent delivery component, and the reagent delivery component mixes the target dose of the diluent with the animal's blood to be tested and performs Hemolysis treatment to obtain test samples. Here, the sampling needle assembly is used to suck the blood of the animal to be tested and send it to the first counting cell assembly.
试剂输送组件将溶血剂与待测动物血液混合,以对待测动物血液进行溶血处理,溶解待测动物血液中的红细胞,保留待测动物血液中的白细胞。The reagent delivery component mixes the hemolytic agent with the blood of the animal to be tested to perform hemolysis treatment on the blood of the animal to be tested, dissolve red blood cells in the blood of the animal to be tested, and retain white blood cells in the blood of the animal to be tested.
采样针组件将待测动物血液送入第一计数池组件中,且试剂输送组件将目标剂量的稀释液以及溶血剂加入第一计数池组件,在第一计数池组件 中对待测动物血液进行稀释和溶血处理,得到检测样本。可选地,试剂输送组件将目标剂量的稀释液一次性加入第一计数池组件中;可选地,试剂输送组件将目标剂量的稀释液分次加入第一计数池组件中。The sampling needle assembly sends the blood of the animal to be tested into the first counting cell assembly, and the reagent delivery assembly adds the target dose of diluent and hemolytic agent to the first counting cell assembly, and dilutes the blood of the animal to be tested in the first counting cell assembly And hemolysis treatment to obtain test samples. Optionally, the reagent delivery component adds the target dose of diluent to the first counting cell component at one time; optionally, the reagent delivery component adds the target dose of diluent to the first counting cell component in batches.
在一示例中,动物血液细胞分析仪设置有存放稀释液的稀释液存放区和存放溶血剂的溶血剂存放区,稀释液存放区和溶血剂存放区分别设置有与第一计数池组件连接的液路,试剂输送组件通过控制对应的液路的开启和关闭控制稀释液存放区的稀释液和溶血剂存放区的溶血剂向第一计数池组件的流入和停止流入。In an example, the animal blood cell analyzer is provided with a diluent storage area for storing diluents and a hemolytic agent storage area for storing hemolytic agents. The diluent storage area and the hemolytic agent storage area are respectively provided with a first counting cell assembly connected to the The liquid path, the reagent delivery component controls the inflow and stop of the inflow and stop of the diluent in the diluent storage area and the hemolyzing agent in the hemolytic agent storage area into the first counting cell component by controlling the opening and closing of the corresponding liquid path.
在一示例中,动物血液细胞分析仪设置有从盛放有待测动物血液的试管中吸取一定量的待测动物血液的采样针,当采样针在注射器的控制下从盛放有待测动物血液的试管中吸取一定量的待测动物血液后,采样针移至第一计数池组件所在的检测区,注射器将采样针中的待测动物血液打入第一计数池组件中,从而将待测动物血液加入第一计数池组件。这里,采样针可先移至第一计数池组件的上方,在注射器将采样针中的待测动物血液打入第一计数池组件之前,采样针可延垂直方向从第一计数池组件的上方移至第一计数池组件的池内,注射器将位于池内的采样针中的待测动物血液打入进第一计数池组件中,从而避免采样针中的待测动物血液溅出第一计数池组件。In one example, the animal blood cell analyzer is provided with a sampling needle that draws a certain amount of blood from the animal to be tested from a test tube containing the blood of the animal to be tested. When the sampling needle is controlled by the syringe, it is removed from the animal to be tested. After a certain amount of blood of the animal to be tested is drawn in the blood test tube, the sampling needle is moved to the detection area where the first counting cell assembly is located, and the syringe pumps the blood of the animal to be tested in the sampling needle into the first counting cell assembly, thereby removing the blood from the animal to be tested. The blood of the test animal is added to the first counting pool assembly. Here, the sampling needle can be moved to the top of the first counting cell assembly first. Before the syringe pumps the blood of the animal to be tested in the sampling needle into the first counting cell assembly, the sampling needle can extend vertically from above the first counting cell assembly. Move to the pool of the first counting cell assembly, and the syringe will inject the blood of the animal to be tested in the sampling needle in the pool into the first counting cell assembly, so as to prevent the blood of the animal to be tested in the sampling needle from splashing out of the first counting cell assembly .
对于不同的目标测量模式,采样针所吸取的待测动物样本的量可相同,也可不同。在实际应用中,同一台动物血液细胞分析仪,采样针从试管中所吸取的待测动物样本的剂量相同,也就是说,加入第一计数池组件中的待测动物血液的剂量相同,从而方便对不同种类的动物的测试结果进行比对。For different target measurement modes, the amount of animal sample to be tested sucked by the sampling needle can be the same or different. In practical applications, the same animal blood cell analyzer, the sampling needle draws the same dose of the animal sample from the test tube, that is to say, the dose of the animal’s blood to be tested added to the first counting cell assembly is the same, so It is convenient to compare the test results of different kinds of animals.
本发明实施例中,试剂输送组件可包括一个或多个注射器,且用于将稀释液、溶血剂加入第一计数池组件的注射器可为一个注射器,也可为不 同的注射器。比如:试剂输送组件包括一个注射器,通过该注射器分别向第一计数池组件中加入稀释液和溶血剂。又比如:试剂输送组件包括第一注射器和第二注射器,第一注射器用于用于将稀释液加入第一计数池组件。第二注射器用于将溶血剂加入第一计数池组件。本发明实施例中对试剂输送组件所包括的注射器的数量以及注射器的作用对象不进行任何的限制。In the embodiment of the present invention, the reagent delivery component may include one or more syringes, and the syringe used to add the diluent and hemolytic agent to the first counting cell component may be one syringe or different syringes. For example, the reagent delivery component includes a syringe through which the diluent and the hemolytic agent are respectively added to the first counting cell component. For another example, the reagent delivery component includes a first syringe and a second syringe, and the first syringe is used to add the diluent to the first counting cell component. The second syringe is used to add the hemolytic agent to the first counting cell assembly. In the embodiment of the present invention, there is no restriction on the number of syringes included in the reagent delivery assembly and the objects of the syringes.
在本发明实施例中,采样针组件将待测动物血液送入第一计数池组件以及试剂输送组件向第一计数池组件中加入稀释液、溶血剂的先后顺序不进行限定。比如:采样针组件和试剂输送组件依次向第一计数池组件中加入稀释液、待测动物血液和溶血剂。又比如:采样针组件和试剂输送组件依次向第一计数池组件中加入稀释液、溶血剂和待测动物血液。再比如:采样针组件和试剂输送组件同时向第一计数池组件中加入稀释液和待测动物血液,在加入稀释液和待测动物血液之后,试剂输送组件向第一计数池组件中加入溶血剂。In the embodiment of the present invention, the sampling needle assembly sends the blood of the animal to be tested into the first counting cell assembly and the sequence of adding the diluent and hemolytic agent to the first counting cell assembly by the reagent delivery assembly is not limited. For example, the sampling needle assembly and the reagent delivery assembly sequentially add diluent, animal blood and hemolytic agent to the first counting cell assembly. For another example: the sampling needle assembly and the reagent delivery assembly sequentially add diluent, hemolytic agent and animal blood to be tested into the first counting cell assembly. For another example: the sampling needle assembly and the reagent delivery assembly simultaneously add the diluent and the animal blood to be tested into the first counting cell assembly, and after adding the diluent and the animal blood to be tested, the reagent delivery assembly adds hemolysis to the first counting cell assembly Agent.
在实际应用中,在加入待测动物血液的同时加入稀释液,通过稀释液对吸取待测动物血液的采样针进行清洗,从而保证采样针中所吸取的待测动物血液能够全部的加入到第一计数池组件中。In practical applications, the diluent is added while adding the blood of the animal to be tested, and the sampling needle that draws the blood of the animal to be tested is cleaned by the diluent, so as to ensure that all the blood of the animal to be tested can be added to the sample needle. A counting cell assembly.
在一实施例中,动物血液细胞分析仪的试剂输送组件在将所述目标剂量的稀释液与待测动物血液进行混合并进行溶血处理之前,将第一计数池组件排空,使得第一计数池组件中的液体清除干净,避免第一计数池组件中的残存的液体对本次测试的测试结果的影响。In one embodiment, the reagent delivery component of the animal blood cell analyzer empties the first counting cell component before mixing the diluent of the target dose with the blood of the animal to be tested and performing hemolysis treatment, so that the first counting The liquid in the pool assembly is cleaned up to avoid the influence of the remaining liquid in the first counting pool assembly on the test results of this test.
在一实施例中,动物血液细胞分析仪的试剂输送组件在将所述目标剂量的稀释液与待测动物血液进行混合并进行溶血处理过程中,当第一计数池组件中包括稀释液、待测动物血液和溶血剂中的至少两种时,对第一计数池组件中的液体进行混匀,以将稀释液和待测动物血液、溶血剂和待测动物血液进行充分反应,保证测试结果的准确性。In one embodiment, the reagent delivery component of the animal blood cell analyzer mixes the diluent of the target dose with the blood of the animal to be tested and performs hemolysis. When the first counting cell component includes the diluent, the When testing at least two of animal blood and hemolytic agent, mix the liquid in the first counting cell assembly to fully react the diluent with the blood of the animal to be tested, the hemolytic agent and the blood of the animal to be tested, and ensure the test result Accuracy.
在本发明实施例中,试剂输送组件向第一计数池组件中加入的溶血剂的剂量可根据动物测量模式进行调整,溶血处理的时间即溶血剂与待测动物血液的反应时间也可根据动物测量模式进行调整。In the embodiment of the present invention, the dosage of the hemolytic agent added by the reagent delivery assembly to the first counting cell assembly can be adjusted according to the animal measurement mode, and the time of hemolysis treatment, that is, the reaction time between the hemolytic agent and the blood of the animal to be tested, can also be adjusted according to the animal The measurement mode is adjusted.
S403、对所述检测样本进行测试,得到白细胞计数和分类结果。S403. Perform a test on the detection sample to obtain a white blood cell count and classification result.
采样针组件将待测动物血液送入第一计数池组件且试剂输送组件将目标剂量的稀释液以及溶血剂加入第一计数池组件后,得到稀释和溶血处理后的检测样本,动物血液细胞分析仪中的检测结果对第一计数池组件中的检测样本进行测试,得到白细胞的计数和分类结果。The sampling needle assembly sends the blood of the animal to be tested into the first counting cell assembly, and the reagent delivery assembly adds the target dose of diluent and hemolytic agent to the first counting cell assembly to obtain the diluted and hemolyzed test sample, and analyze the animal blood cells The test result in the instrument tests the test sample in the first counting cell component to obtain the white blood cell count and classification result.
可选地,在第一计数池组件中得到检测样本后,动物血液细胞分析仪基于用户的操作触发第一计数池组件对检测样本的测试。可选地,在第一计数池组件中得到检测样本后,动物血液细胞分析仪自动触发第一计数池组件对检测样本的测试。在一示例中,动物血液细胞分析仪基于溶血剂和待测动物血液的反应时间自动触发第一计数池组件对检测样本的测试。Optionally, after the test sample is obtained in the first counting cell component, the animal blood cell analyzer triggers the first counting cell component to test the test sample based on the user's operation. Optionally, after the test sample is obtained in the first counting cell component, the animal blood cell analyzer automatically triggers the first counting cell component to test the test sample. In an example, the animal blood cell analyzer automatically triggers the test of the test sample by the first counting cell component based on the reaction time of the hemolytic agent and the blood of the animal to be tested.
第一计数池组件在得到白细胞计数和分类结果后,可将白细胞计数和分类结果发送至动物血液细胞分析仪的显示器,通过动物血液细胞分析仪的显示器呈现给检测人员,也可将白细胞计数和分类结果发送至动物血液细胞分析仪以外的其他设备的显示器,通过其他设备的显示器呈现给检测人员。这里,动物血液细胞分析仪与其他设备可通过有线、无线等方式进行连接。After the first counting cell component obtains the white blood cell count and classification results, it can send the white blood cell count and classification results to the display of the animal blood cell analyzer, and present it to the inspector through the display of the animal blood cell analyzer, and can also display the white blood cell count and classification results. The classification results are sent to the display of other equipment other than the animal blood cell analyzer, and presented to the inspector through the display of other equipment. Here, the animal blood cell analyzer and other equipment can be connected via wired or wireless methods.
在本发明实施例中,基于动物种类对应的动物测量模式确定用于对动物血液进行稀释的稀释液的目标剂量,以通过目标剂量的稀释液对待测动物血液进行稀释,从而在对待测动物血液进行测试时,对不同种类的动物的血液,使用对应剂量的稀释液对待测动物血液进行稀释,通过控制稀释液的剂量,提高淋巴细胞等白细胞的测试结果的准确性。In the embodiment of the present invention, the target dose of the diluent used to dilute the animal’s blood is determined based on the animal measurement mode corresponding to the animal species, so that the target dose of the diluent is used to dilute the blood of the animal to be tested, so that the blood of the animal to be tested is diluted During the test, the blood of different types of animals is diluted with the corresponding dose of diluent to dilute the blood of the animal to be tested. By controlling the dosage of the diluent, the accuracy of the test results of lymphocytes and other white blood cells is improved.
在本发明实施例中,对于不同种类的动物,可通过调整稀释液的剂量、 溶血剂的剂量以及溶血剂与待测动物血液的反应时间,对待测动物血液的稀释和溶血处理进行调整,以提高各种动物血液的白细胞分类和计数结果的准确性。In the embodiment of the present invention, for different kinds of animals, the dilution and hemolysis treatment of the blood of the animal to be tested can be adjusted by adjusting the dosage of the diluent, the dosage of the hemolytic agent, and the reaction time of the hemolytic agent with the blood of the animal to be tested. Improve the accuracy of white blood cell classification and counting results of various animal blood.
基于图1所示的动物血液细胞分析仪,本发明实施例提供的动物血液细胞分析仪还可如图5所示,包括:显示器105和输入装置106。其中,显示器105,用于显示软件界面,输入装置106,包括键盘或鼠标等供用户输入信息或指令的装置。在本发明实施例中,显示器105和输入装置106可集成为触控显示器,在显示软件界面的同时,接收用户输入的信息或指令。Based on the animal blood cell analyzer shown in FIG. 1, the animal blood cell analyzer provided by the embodiment of the present invention may also include a display 105 and an input device 106 as shown in FIG. 5. Among them, the display 105 is used to display a software interface, and the input device 106 includes a keyboard or a mouse for the user to input information or instructions. In the embodiment of the present invention, the display 105 and the input device 106 may be integrated as a touch display, which can receive information or instructions input by the user while displaying the software interface.
在一实施例中,基于图5所示动物血液细胞分析仪,S401从多种动物测量模式中选中目标测量模式,包括:输出动物测量模式选择界面;接收针对所述测量模式选择界面中的动物测量模式的输入操作或选择操作;根据所述输入操作或所述选择操作从多种动物测量模式中确定目标测量模式。In one embodiment, based on the animal blood cell analyzer shown in FIG. 5, S401 selects a target measurement mode from a variety of animal measurement modes, including: outputting an animal measurement mode selection interface; receiving an animal in the measurement mode selection interface The input operation or the selection operation of the measurement mode; the target measurement mode is determined from a plurality of animal measurement modes according to the input operation or the selection operation.
这里,显示器105,用于输出动物测量模式选择界面;输入装置106,用于接收针对所述测量模式选择界面中的动物测量模式的输入操作或选择操作;模式选择模块102,用于根据所述输入操作或所述选择操作从多种动物测量模式中确定目标测量模式。Here, the display 105 is used to output the animal measurement mode selection interface; the input device 106 is used to receive input operations or selection operations for the animal measurement mode in the measurement mode selection interface; the mode selection module 102 is used to The input operation or the selection operation determines the target measurement mode from a plurality of animal measurement modes.
显示器可输出用于选择动物测量模式的动物测量模式选择界面,在动物测量模式中可显示多种动物测量模式或动物种类,使得用户基于动物测量模式选择界面通过输入装置输入当前待测的动物的种类或目标测量模式,当用户输入的信息为动物的种类时,模式选择模块可从多种动物测量模式中确定输入的动物的种类对应的动物测量模式作为目标测量模式。The display can output an animal measurement mode selection interface for selecting an animal measurement mode. In the animal measurement mode, a variety of animal measurement modes or animal types can be displayed, so that the user can input the current animal measurement mode through the input device based on the animal measurement mode selection interface. Type or target measurement mode. When the information input by the user is the type of animal, the mode selection module can determine the animal measurement mode corresponding to the input animal type from multiple animal measurement modes as the target measurement mode.
输入装置可接收用户的输入操作或选择操作。在输入装置接收用户的输入操作的情况下,在动物测量模式选择界面中可提供输入接口,通过输入接口接收用户输入的动物种类或目标测量模式。在输入装置接收用户的 输入操作的情况下,在动物测量模式选择界面中可提供多种动物种类或动物测量模式,并确定用户所选择的动物种类或目标测量模式。The input device can receive the user's input operation or selection operation. When the input device receives the user's input operation, an input interface may be provided in the animal measurement mode selection interface, and the animal type or target measurement mode input by the user is received through the input interface. When the input device receives the user's input operation, a variety of animal types or animal measurement modes can be provided in the animal measurement mode selection interface, and the animal type or target measurement mode selected by the user is determined.
基于图1所示的动物血液细胞分析仪,本发明实施例提供的动物血液细胞分析仪还可如图5所示,包括:扫描仪107。其中,扫描仪107,用于对条形码、二维码等信息标识进行扫描,得到信息标识所携带的信息。Based on the animal blood cell analyzer shown in FIG. 1, the animal blood cell analyzer provided by the embodiment of the present invention may also include a scanner 107 as shown in FIG. 5. Among them, the scanner 107 is used to scan information identifiers such as barcodes and two-dimensional codes to obtain the information carried by the information identifiers.
在一实施例中,基于图5所示动物血液细胞分析仪,从多种动物测量模式中选中目标测量模式,包括:扫描盛放所述待测动物血液的试管上的信息标识,得到所述待测动物血液的样本信息;根据所述样本信息,从多种动物测量模式中选中目标测量模式。In one embodiment, based on the animal blood cell analyzer shown in FIG. 5, selecting a target measurement mode from a variety of animal measurement modes, including: scanning the information identifier on the test tube containing the blood of the animal to be tested to obtain the Sample information of the blood of the animal to be tested; according to the sample information, a target measurement mode is selected from a variety of animal measurement modes.
这里,所述扫描仪107,用于扫描盛放所述待测动物血液的试管上的信息标识,得到所述待测动物血液的样本信息;模式选择模块102,用于根据所述样本信息,从多种动物测量模式中选中目标测量模式。Here, the scanner 107 is used to scan the information identifier on the test tube containing the blood of the animal to be tested to obtain sample information of the blood of the animal to be tested; the mode selection module 102 is used to, according to the sample information, Select the target measurement mode from a variety of animal measurement modes.
盛放待测动物血液的试管上贴附有标签,且标签上有携带待测动物血液的信息的条形码、二维码等信息标识,信息标识所携带的信息可包括:待测动物血液所属的动物的种类、待测动物血液的通用唯一识别码(Universally Unique Identifier,UUID),测试项目等待测动物血液的样本信息。本发明实施例中对信息标识所携带的样本信息不进行任何的限定。The test tube containing the blood of the animal to be tested is affixed with a label, and the label contains a barcode, two-dimensional code and other information identifiers that carry the information of the animal’s blood to be tested. The information carried by the information identifier may include: the blood of the animal to be tested belongs to The type of animal, the Universally Unique Identifier (UUID) of the animal's blood to be tested, and the test item is waiting to test the blood sample information of the animal. In the embodiment of the present invention, the sample information carried by the information identifier is not limited in any way.
当盛放待测动物血液的试管位于扫描仪的扫描范围内,扫描仪对试管上的信息标识进行扫描,得到信息标识所携带的待测动物血液的样本信息,并将扫描到的待测动物血液的样本信息发送至模式选择模块,模式选择模块根据扫描仪扫描的样本信息中与动物种类或动物测量模式有关的样本信息确定该试管中的待测动物血液对应的动物测量模式即目标测量模式。When the test tube containing the blood of the animal to be tested is within the scanning range of the scanner, the scanner scans the information mark on the test tube to obtain the sample information of the blood of the animal to be tested carried by the information mark, and then scan the scanned animal to be tested The blood sample information is sent to the mode selection module, and the mode selection module determines the animal measurement mode corresponding to the animal blood in the test tube according to the sample information related to the animal type or the animal measurement mode in the sample information scanned by the scanner, that is, the target measurement mode .
比如:扫描仪扫描到的样本信息中包括表征动物测量模式的信息,且动物测量模式为猫类测量模式,则模式选择模块确定目标测量模式为猫类测量模式。又比如:扫描仪扫描到的样本信息中包括待测动物血液所属的 动物种类,且动物种类为猫,则模选择模块确定目标测量模式为猫类测量模式。再比如,扫描仪扫描到的样本信息中包括待测动物血液的样本ID即UUID,且样本标识为1111,模式选择模块根据样本标识1111确定待测动物血液对应的动物测量模式为猫类测量模式,则确定目标测量模式为猫类测量模式。For example, if the sample information scanned by the scanner includes information that characterizes the animal measurement mode, and the animal measurement mode is a cat measurement mode, the mode selection module determines that the target measurement mode is a cat measurement mode. For another example: the sample information scanned by the scanner includes the animal species to which the blood of the animal to be tested belongs, and the animal species is cat, then the model selection module determines that the target measurement mode is the cat measurement mode. For another example, the sample information scanned by the scanner includes the UUID, which is the sample ID of the blood of the animal to be tested, and the sample ID is 1111. The mode selection module determines that the animal measurement mode corresponding to the blood of the animal to be tested is the cat measurement mode according to the sample ID 1111. , The target measurement mode is determined to be the cat measurement mode.
在本发明实施例中,基于目标剂量的稀释液是否一次性加入第一计数池组件,本发明实施例中在向第一计数池组件中加入稀释液、待测动物血液和溶血剂的加入方式可包括:In the embodiment of the present invention, based on whether the diluent of the target dose is added to the first counting cell assembly at one time, in the embodiment of the present invention, the method of adding the diluent, the blood of the animal to be tested, and the hemolytic agent to the first counting cell assembly Can include:
加入方式一、一次性加入Join method one, one-time join
在加入方式一中,S402将所述目标剂量的稀释液与待测动物血液进行混合并进行溶血处理,得到检测样本,包括:向第一计数池组件中加入目标剂量的稀释液;向所述第一计数池组件中加入溶血剂和所述待测动物血液,得到检测样本。这里,采样针组件将待测动物血液送入第一计数池组件,所述试剂输送组件向所述第一计数池组件中加入目标剂量的稀释液;并向所述第一计数池组件中加入溶血剂。In the first method of adding, S402 mixes the diluent of the target dose with the blood of the animal to be tested and performs hemolysis treatment to obtain a test sample, including: adding the diluent of the target dose to the first counting cell assembly; The hemolytic agent and the blood of the animal to be tested are added to the first counting cell component to obtain a test sample. Here, the sampling needle assembly sends the blood of the animal to be tested into the first counting pool assembly, and the reagent delivery assembly adds a target dose of diluent to the first counting pool assembly; and adds to the first counting pool assembly Hemolytic agent.
试剂输送组件向第一计数池组件中加入稀释液时,直接向第一计数池组件中加入目标剂量的稀释液,并在加入目标剂量的稀释液后,向第一计数池组件中加入和溶血剂。其中,采样针可在试剂输送组件向第一计数池组件中加入稀释液的过程中或之后,将待测动物血液送入第一计数池组件。比如:试剂输送组件向第一计数池组件中加入目标剂量的稀释液,且在试剂输送组件加入目标剂量的稀释液后,采样针组件向第一计数池组件中加入待测动物血液,在采样针组件加入待测动物血液后,试剂输送组件继续向第一计数池组件中加入溶血剂。又比如:试剂输送组件向第一计数池组件中加入目标剂量的稀释液的过程中,采样针组件向第一计数池组件中加入待测动物血液,在采样针组件向第一计数池组件加入待测动物血液后, 试剂输送组件继续向第一计数池组件中加入溶血剂。When the reagent delivery component adds the diluent to the first counting cell component, it directly adds the target dose of diluent to the first counting cell component, and after adding the target dose of diluent, adds and hemolyzes to the first counting cell component Agent. Wherein, the sampling needle can send the blood of the animal to be tested into the first counting cell component during or after the reagent delivery component adds the diluent to the first counting cell component. For example, the reagent delivery component adds the target dose of diluent to the first counting cell component, and after the reagent delivery component adds the target dose of diluent, the sampling needle component adds the blood of the animal to be tested to the first counting cell component, and then the sample After the needle assembly is added to the blood of the animal to be tested, the reagent delivery assembly continues to add the hemolytic agent to the first counting cell assembly. For another example, when the reagent delivery component adds the target dose of diluent to the first counting cell component, the sampling needle component adds the blood of the animal to be tested into the first counting cell component, and the sampling needle component adds the first counting cell component to the first counting cell component. After the blood of the animal to be tested, the reagent delivery component continues to add the hemolytic agent to the first counting cell component.
在本发明实施例中,在一次性加入目标剂量的稀释液的情况下,添加稀释液的过程不间断,但对稀释液、溶血剂和待测动物血液的加入先后顺序不进行任何的限定。In the embodiment of the present invention, when the target dose of the diluent is added at one time, the process of adding the diluent is uninterrupted, but the order of adding the diluent, hemolytic agent, and animal blood to be tested is not limited in any way.
加入方式二、分次加入Join method two, join in by stages
在加入方式一中,S402将所述目标剂量的稀释液与待测动物血液进行混合并进行溶血处理,包括:向第一剂量的稀释液中加入所述待测动物血液,得到参考检测样本;向所述参考检测样本中加入第二剂量的稀释液和溶血剂,得到所述检测样本,所述第一剂量和所述第二剂量的和为所述目标剂量。这里,所述试剂输送组件,在所述采样针组件将所述待测动物血液送入所述第一计数池中之前或之时,向第一计数池组件中加入第一剂量的稀释液;并在向所述第一计数池组件中加入待测动物血液之后,向所述第一计数池组件中加入第二剂量的稀释液和所述溶血剂。In addition method 1, S402 mixing the target dose of diluent with the blood of the animal to be tested and performing hemolysis treatment includes: adding the blood of the animal to be tested to the first dose of diluent to obtain a reference test sample; A second dose of diluent and hemolytic agent are added to the reference test sample to obtain the test sample, and the sum of the first dose and the second dose is the target dose. Here, the reagent delivery component adds a first dose of diluent to the first counting cell before or while the sampling needle component sends the blood of the animal to be tested into the first counting cell; And after adding the blood of the animal to be tested into the first counting cell component, a second dose of diluent and the hemolytic agent are added to the first counting cell component.
试剂输送组件首先向第一计数池组件中加入第一剂量的稀释液,且采样针组件向第一计数池组件中加入待测动物血液,在采样针组件向第一计数池组件加入待测动物血液后,试剂输送组件继续向第一计数池组件中加入第二剂量的稀释液,并加入溶血剂,从而先向第一计数池组件中加入第一剂量的稀释液,再向第一计数池组件中加入第二剂量的稀释液。The reagent delivery component first adds the first dose of diluent to the first counting cell component, and the sampling needle component adds the blood of the animal to be tested to the first counting cell component, and the animal to be tested is added to the first counting cell component in the sampling needle component. After the blood, the reagent delivery component continues to add the second dose of diluent to the first counting cell component, and adds the hemolytic agent, so that the first dose of diluent is added to the first counting cell component, and then to the first counting cell Add a second dose of diluent to the assembly.
这里,试剂输送组件向第一计数池组件中加入第一剂量的稀释液的执行可在采样针组件向第一计数池组件中加入待测动物血液之前,也可与采样针组件向第一计数池组件中加入待测动物血液同时执行。Here, the reagent delivery component adding the first dose of diluent to the first counting cell component can be executed before the sampling needle component adds the blood of the animal to be tested to the first counting cell component, or it can be combined with the sampling needle component to the first counting. Adding the blood of the animal to be tested into the pool assembly is performed at the same time.
对于不同的动物测量模式所加入的待测动物血液的剂量相同的情况下,第一剂量的大小可相同,也可不同。In the case where the dose of blood of the animal to be tested added in different animal measurement modes is the same, the size of the first dose may be the same or different.
在一实施例中,动物血液细胞分析仪在向所述参考检测样本中加入第二剂量的稀释液和溶血剂之前,从所述参考检测样本中吸取固定剂量的所 述参考检测样本;对所述固定剂量的所述参考检测样本进行红细胞测试和/或血小板测试。这里,动物血液细胞分析仪中的采样针组件从所述第一计数池组件中吸取固定剂量的由所述第一剂量的稀释液和所述待测动物血液构成的参考检测样本;所述第二计数池组件,对所述固定剂量的所述参考检测样本进行红细胞测试和/或血小板测试。In one embodiment, the animal blood cell analyzer draws a fixed dose of the reference test sample from the reference test sample before adding the second dose of diluent and hemolytic agent to the reference test sample; The fixed dose of the reference test sample is subjected to red blood cell test and/or platelet test. Here, the sampling needle assembly in the animal blood cell analyzer draws a fixed dose of a reference test sample composed of the first dose of diluent and the animal blood to be tested from the first counting cell assembly; the first The second counting cell component performs red blood cell test and/or platelet test on the reference test sample of the fixed dose.
第二计数池组件为与第一计数池组件不同的计数池组件。可选地,第二计数池组件和第一计数池组件属于同一动物血液细胞分析仪。可选地,第二计数池组件和第一计数池组件属于不同的动物血液细胞分析仪。The second counting cell component is a different counting cell component from the first counting cell component. Optionally, the second counting cell component and the first counting cell component belong to the same animal blood cell analyzer. Optionally, the second counting cell component and the first counting cell component belong to different animal blood cell analyzers.
在第一计数池组件中加入溶血剂以形成检测样本之前,第一计数池组件中仅包括第一剂量的稀释液和待测动物血液,即第一计数池组件中为对待测动物血液进行稀释的参考检测样本,此时,可由采样针组件从第一计数池组件中吸取参考检测样本,并由第二计数池组件对采样针吸取的参考检测样本进行与红细胞相关的以下测试至少之一:红细胞测试和血小板测试。Before adding the hemolytic agent to the first counting cell component to form a test sample, the first counting cell component only includes the first dose of diluent and the animal's blood to be tested, that is, the first counting cell component is for diluting the blood of the animal to be tested At this time, the reference test sample can be drawn from the first counting cell assembly by the sampling needle assembly, and the second counting cell assembly can perform at least one of the following red blood cell-related tests on the reference test sample drawn by the sampling needle: Red blood cell test and platelet test.
采样针组件从第一计数池组件中吸取的参考检测样本的剂量即固定剂量的大小可为9uL、11uL等。固定剂量的大小可根据实际需求设定,本发明实施例对此不进行任何限定。The dose of the reference test sample drawn by the sampling needle assembly from the first counting cell assembly, that is, the size of the fixed dose can be 9uL, 11uL, and so on. The size of the fixed dose can be set according to actual needs, which is not limited in the embodiment of the present invention.
在一实施例中,对于不同的动物测量模式,所述第一剂量相同。In one embodiment, for different animal measurement modes, the first dose is the same.
对于不同的动物测量模式,即不同的动物种类,参考检测样本中的待测动物样本的剂量相同,且稀释液的剂量相同的情况下,不同动物种类对应的参考检测样本的稀释比相同,从而方便对不同动物种类的红细胞检测或血小板检测结果进行比对。For different animal measurement modes, that is, different animal species, the reference test sample has the same dose of the animal sample to be tested, and the same diluent dose, the dilution ratio of the reference test sample corresponding to different animal species is the same, so It is convenient to compare the red blood cell test or platelet test results of different animal species.
在加入方式二中,基于第一剂量的稀释液是否是一次性加入第一计数池组件,加入方式二可包括以下两种情况:In the second addition method, based on whether the first dose of diluent is added to the first counting cell assembly at one time, the second addition method can include the following two situations:
情况一、第一剂量的稀释液一次性加入Case 1: The first dose of diluent is added all at once
在情况一中,所述向第一剂量的稀释液中加入所述待测动物血液,得到参考检测样本,包括:向第一计数池组件中加入第一剂量的稀释液;向所述第一计数池组件中加入所述待测动物血液,得到参考检测样本。这里,试剂输送组件在所述采样针组件将待测动物血液送入所述第一计数池组件之前,向所述第一计数池组件中加入第一剂量的稀释液。In case 1, adding the blood of the animal to be tested to the first dose of diluent to obtain a reference test sample includes: adding the first dose of diluent to the first counting cell assembly; The blood of the animal to be tested is added to the counting pool assembly to obtain a reference test sample. Here, the reagent delivery component adds the first dose of diluent to the first counting cell component before the sampling needle component sends the blood of the animal to be tested into the first counting cell component.
情况二、第一剂量的稀释液分次加入Case 2: The first dose of diluent is added in portions
在情况二中,所述向第一剂量的稀释液中加入所述待测动物血液,得到参考检测样本,包括:向第一计数池组件中加入第三剂量的稀释液;向所述第一计数池组件加入第四剂量的稀释液和所述待测动物血液,得到参考检测样本,所述第三剂量和所述第四剂量的和为所述第一剂量。这里,试剂输送组件在所述采样针组件将待测动物血液送入所述第一计数池组件之前,向第一计数池组件向第一计数池组件中加入第三剂量的稀释液;并在所述采样针组件将待测动物血液送入所述第一计数池组件之时,向所述第一计数池组件中加入第四剂量的稀释液和所述待测动物血液。In the second case, adding the blood of the animal to be tested to the first dose of diluent to obtain a reference test sample includes: adding a third dose of diluent to the first counting cell assembly; A fourth dose of diluent and the blood of the animal to be tested are added to the counting cell assembly to obtain a reference test sample, and the sum of the third dose and the fourth dose is the first dose. Here, the reagent delivery component adds a third dose of diluent to the first counting cell component to the first counting cell component before the sampling needle component sends the blood of the animal to be tested into the first counting cell component; and When the sampling needle assembly sends the blood of the animal to be tested into the first counting pool assembly, a fourth dose of diluent and the blood of the animal to be tested are added to the first counting pool assembly.
需要说明的是,情况一和情况二分别为将目标剂量的稀释液分两次加入第一计数池组件和分三次加入第一计数池组件的示例,在实际应用中,将目标剂量的稀释液分次加的次数,以及同溶血剂、待测血液的加入顺序可根据实际需求进行控制。It should be noted that Case 1 and Case 2 are examples of adding the diluent of the target dose to the first counting cell assembly in two and three times. In practical applications, the diluent of the target dose is added to the first counting cell assembly. The number of times of adding in batches, and the order of adding the same hemolytic agent and blood to be tested can be controlled according to actual needs.
试剂输送组件和采样针组件可同时向第一计数池组件中加入第四剂量的稀释液和所述待测动物血液,通过所加入的稀释液对采样针上的待测动物血液进行冲洗,保证待测动物血液能够全部加入第一计数池组件中,保证分类和计数结果的准确性。The reagent delivery assembly and the sampling needle assembly can simultaneously add a fourth dose of diluent and the blood of the animal to be tested into the first counting cell assembly, and the blood of the animal to be tested on the sampling needle is washed by the added diluent to ensure The blood of the animal to be tested can all be added to the first counting pool component to ensure the accuracy of classification and counting results.
本发明实施例提供的动物血液细胞分析方法,操作人员可根据实际需求灵活设置目标剂量的稀释液加入流程,比如:在加入目标剂量的稀释液时,先向第一计数池组件中加入第一剂量的稀释液和待测动物血液,再向 第一计数池组件中加入第二剂量的稀释液和溶血剂,从而在形成检测样本的过程中,得到参考检测样本,能够在进行白细胞测试的同时,进行红细胞测试、血小板测试等与红细胞有关的测试。In the animal blood cell analysis method provided by the embodiments of the present invention, the operator can flexibly set the target dose of diluent adding process according to actual needs. For example, when adding the target dose of diluent, first add the first counting cell assembly to the first counting cell assembly. Dose of diluent and animal blood to be tested, and then add a second dose of diluent and hemolytic agent to the first counting cell assembly, so that in the process of forming the test sample, a reference test sample can be obtained, which can be used for white blood cell testing at the same time , Carry out red blood cell test, platelet test and other tests related to red blood cells.
下面,通过具体的测试场景对本发明实施例提供的动物血液细胞分析方法进行说明,如图6所示,包括:In the following, the animal blood cell analysis method provided by the embodiment of the present invention will be described through specific test scenarios, as shown in FIG. 6, including:
S601、采样针组件吸取待测动物血液。S601. The sampling needle assembly sucks blood of the animal to be tested.
采样针组件从试管中吸取指定剂量的待测动物血液。The sampling needle assembly draws a specified dose of animal blood to be tested from the test tube.
S602、第一计数池组件排空。S602. The first counting pool component is emptied.
S603、试剂输送组件向第一计数池组件中加入第一剂量的稀释液。S603: The reagent delivery component adds a first dose of diluent to the first counting cell component.
试剂输送组件中的注射器打开第一计数池组件与稀释液存放位之间的液路,通过打开的液路向第一计数池组件中加入稀释液,并在加入第一剂量的稀释液后,将打开的液路关闭。在此过程中,第一计数池组件与溶血剂存放位之间的液路处于关闭状态。The syringe in the reagent delivery assembly opens the liquid path between the first counting cell assembly and the diluent storage position, adds the diluent to the first counting cell assembly through the opened liquid path, and after adding the first dose of diluent, the The opened hydraulic circuit is closed. During this process, the liquid path between the first counting cell component and the hemolytic agent storage position is in a closed state.
S604、采样针组件向第一计数池组件中加入待测动物血液。S604: The sampling needle assembly adds blood of the animal to be tested into the first counting cell assembly.
采样针组件中的注射器控制采样针从用于从试管中吸取待测动物血液的吸样区移动至用于对血样进行检测的检测区中第一计数池组件的上方,并从第一计数池组件的上方移动至第一计数池组件的池内,采样针组件中的注射器将位于第一计数池组件池内的采样针中的待测动物血液打入第一计数池组件。The syringe in the sampling needle assembly controls the sampling needle to move from the sampling area for sucking the blood of the animal to be tested from the test tube to above the first counting cell assembly in the detection area for detecting the blood sample, and from the first counting cell The upper part of the assembly moves into the pool of the first counting cell assembly, and the syringe in the sampling needle assembly injects the blood of the animal to be tested in the sampling needle in the first counting cell assembly into the first counting cell assembly.
S605、混匀。S605, mix well.
将第一计数池组件中的稀释液和待测动物血液混匀,得到参考检测样本。Mix the diluent in the first counting cell assembly with the blood of the animal to be tested to obtain a reference test sample.
S606、采样针组件从第一计数池组件中吸取参考检测样本,以进行红细胞测试和血小板测试。S606. The sampling needle assembly draws a reference test sample from the first counting cell assembly to perform red blood cell test and platelet test.
S607、试剂输送组件向第一计数池组件中加入溶血剂。S607: The reagent delivery component adds a hemolytic agent to the first counting cell component.
试剂输送组件中的注射器打开第一计数池组件与溶血剂存放位之间的液路,通过打开的液路向第一计数池组件中加入溶血剂,并在加入溶血剂后,将打开的液路关闭。在此过程中,第一计数池组件与稀释液存放位之间的液路处于关闭状态。The syringe in the reagent delivery assembly opens the liquid path between the first counting cell assembly and the hemolytic agent storage position, and adds the hemolytic agent to the first counting cell assembly through the opened liquid path. After adding the hemolytic agent, the opened liquid path is opened shut down. During this process, the liquid path between the first counting cell component and the diluent storage position is in a closed state.
S608、试剂输送组件向第一计数池组件中加入第二剂量的稀释液。S608: The reagent delivery component adds a second dose of diluent to the first counting cell component.
试剂输送组件向第一计数池组件中加入稀释液的过程同S603。The process of adding the diluent into the first counting cell assembly by the reagent delivery assembly is the same as S603.
S609、混匀。S609. Mix well.
将第一计数池组件中的稀释液、待测动物血液和溶血剂混匀,得到检测样本。Mix the diluent in the first counting cell assembly, the blood of the animal to be tested, and the hemolytic agent to obtain a test sample.
S610、第一计数池组件进行测试。S610, the first counting cell component is tested.
第一计数池组件对第一计数池组件中的参考样本进行测试,得到白细胞计数和分类结果。The first counting cell component tests the reference sample in the first counting cell component to obtain white blood cell count and classification results.
本发明实施例提供的动物血液细胞分析方法,在不同动物种类间进行白细胞通道测试时,不同动物间,使用不同的稀释液用量,结合调整溶血剂量和溶血时间,在保证白细胞计数值测试结果准确性的前提下,提供淋巴细胞测试结果的准确性。The animal blood cell analysis method provided by the embodiment of the present invention uses different diluent dosages between different animal species when performing white blood cell channel test between different animal species, combined with adjusting the hemolysis dose and hemolysis time, so as to ensure the accuracy of the white blood cell count test result. Under the premise of sex, provide the accuracy of lymphocyte test results.
在未采用本发明实施例提供的动物血液细胞分析方法之前,小鼠的血样中的淋巴细胞百分比为65%,对该血样进行镜检,镜检结果中淋巴细胞百分比为75%,镜检结果和实测结果有10%的差异。我们测试时会发现:不是一个样本,几乎所有样本都有同样问题,通过不同溶血剂加入量的调整,反应时间的增加,淋巴细胞的计数会有改善,但不能彻底解决淋巴细胞的计数不准确的问题。本发明实施例提供的动物血液细胞分析方法,通过改变稀释液量,可以进一步提高淋巴细胞测试结果的准确性。Before the animal blood cell analysis method provided by the embodiment of the present invention is used, the percentage of lymphocytes in the blood sample of the mouse is 65%. The blood sample is microscopically examined, and the percentage of lymphocytes in the microscopic examination result is 75%. The result of the microscopic examination is There is a 10% difference from the actual measurement result. When we test, we will find that it is not a sample, almost all samples have the same problem. By adjusting the amount of different hemolytic agents added, the reaction time will increase, and the lymphocyte count will be improved, but the inaccurate lymphocyte count cannot be completely resolved. The problem. The animal blood cell analysis method provided by the embodiment of the present invention can further improve the accuracy of the lymphocyte test result by changing the amount of the diluent.
下面,通过不同种类动物的血样中淋巴细胞的计数结果对本发明实施例提供的动物血液细胞分析方法的测试结果进行说明。Hereinafter, the test results of the animal blood cell analysis method provided in the embodiment of the present invention will be described through the count results of lymphocytes in blood samples of different types of animals.
本实施例中采血量可以为9ul。调整之前,所有的测量模式均对应2.4ml的稀释液。表1采集了7匹马的血液形成7个待测动物血液,并将调整后的稀释液量设定为1.4ml,对调整稀释液量前的淋巴细胞的百分比、对调整稀释液量后的淋巴细胞的百分比以及镜检结果中淋巴细胞的百分比进行比较。表2采集了7只小鼠的血液形成7个待测动物血液,并将调整后的稀释液量设定为1.6ml,对调整稀释液量前的淋巴细胞的百分比、对调整稀释液量后的淋巴细胞的百分比以及镜检结果中淋巴细胞的百分比进行比较。其中,Lym%代表淋巴细胞百分比。The amount of blood collected in this embodiment can be 9ul. Before adjustment, all measurement modes correspond to 2.4ml diluent. Table 1 collected the blood of 7 horses to form the blood of 7 animals to be tested, and set the adjusted diluent volume to 1.4ml. The percentage of lymphocytes before the diluent volume was adjusted, and the diluent volume after the diluent volume was adjusted. The percentage of lymphocytes and the percentage of lymphocytes in the microscopic examination results are compared. Table 2 The blood of 7 mice was collected to form 7 animal blood to be tested, and the adjusted dilution volume was set to 1.6ml, the percentage of lymphocytes before the adjustment of the dilution volume, and the adjustment of the dilution volume The percentage of lymphocytes and the percentage of lymphocytes in the microscopic examination results are compared. Among them, Lym% represents the percentage of lymphocytes.
表1、Table 1,
表2、Table 2,
通过表1和表2可看出,通过调整不同动物在白细胞计数中血样稀释液的用量,能够在保证白细胞计数结果准确性的基础上,保证淋巴细胞测试结果的准确性。It can be seen from Table 1 and Table 2 that by adjusting the amount of blood sample diluent in the white blood cell count of different animals, the accuracy of the lymphocyte test result can be ensured on the basis of ensuring the accuracy of the white blood cell count result.
本发明实施例再提供一种存储介质,即计算机可读存储介质,所述存储介质上存储有可执行程序,所述可执行程序被处理器执行时,实现上述动物血液细胞分析仪执行的动物血液细胞分析方法的步骤。The embodiment of the present invention further provides a storage medium, that is, a computer-readable storage medium, and an executable program is stored on the storage medium. When the executable program is executed by a processor, the animal blood cell analyzer can be executed by the animal blood cell analyzer. Steps of blood cell analysis method.
以上介质实施例的描述,与上述方法实施例的描述是类似的,具有同方法实施例相似的有益效果。对于本发明存储介质实施例中未披露的技术细节,请参照本发明方法实施例的描述而理解。The description of the above medium embodiment is similar to the description of the above method embodiment, and has similar beneficial effects as the method embodiment. For technical details not disclosed in the embodiment of the storage medium of the present invention, please refer to the description of the method embodiment of the present invention for understanding.
本发明实施例中,如果以软件功能模块的形式实现上述的动物血液细胞分析方法,并作为独立的产品销售或使用时,也可以存储在一个计算机可读取存储介质中。基于这样的理解,本发明实施例的技术方案本质上或者说对现有技术做出贡献的部分可以以软件产品的形式体现出来,该计算机软件产品存储在一个存储介质中,包括若干指令用以使得一台计算机设备(可以是个人计算机、服务器、或者网络设备等)执行本发明各个实施例所述方法的全部或部分。而前述的存储介质包括:U盘、移动硬盘、只读存储器(ROM,Read Only Memory)、磁碟或者光盘等各种可以存储程序代码的介质。这样,本发明实施例不限制于任何特定的硬件和软件结合。In the embodiment of the present invention, if the above animal blood cell analysis method is implemented in the form of a software functional module and sold or used as an independent product, it can also be stored in a computer readable storage medium. Based on this understanding, the technical solutions of the embodiments of the present invention can be embodied in the form of a software product in essence or a part that contributes to the prior art. The computer software product is stored in a storage medium and includes several instructions for A computer device (which may be a personal computer, a server, or a network device, etc.) executes all or part of the methods described in the various embodiments of the present invention. The aforementioned storage media include: U disk, mobile hard disk, Read Only Memory (ROM, Read Only Memory), magnetic disk or optical disk and other media that can store program codes. In this way, the embodiments of the present invention are not limited to any specific combination of hardware and software.
应理解,说明书通篇中提到的“一个实施例”或“一实施例”意味着与实施例有关的特定特征、结构或特性包括在本发明的至少一个实施例中。因此,在整个说明书各处出现的“在一个实施例中”或“在可选地实施例 中”未必一定指相同的实施例。此外,这些特定的特征、结构或特性可以任意适合的方式结合在一个或多个实施例中。应理解,在本发明的各种实施例中,上述各过程的序号的大小并不意味着执行顺序的先后,各过程的执行顺序应以其功能和内在逻辑确定,而不应对本发明实施例的实施过程构成任何限定。上述本发明实施例序号仅仅为了描述,不代表实施例的优劣。It should be understood that “one embodiment” or “an embodiment” mentioned throughout the specification means that a specific feature, structure, or characteristic related to the embodiment is included in at least one embodiment of the present invention. Therefore, the appearance of "in one embodiment" or "in an alternative embodiment" in various places throughout the specification does not necessarily refer to the same embodiment. In addition, these specific features, structures or characteristics can be combined in one or more embodiments in any suitable manner. It should be understood that, in various embodiments of the present invention, the size of the sequence numbers of the foregoing processes does not mean the order of execution. The execution order of the processes should be determined by their functions and internal logic, and should not be used in the embodiments of the present invention. The implementation process constitutes any limitation. The sequence numbers of the foregoing embodiments of the present invention are only for description, and do not represent the superiority of the embodiments.
需要说明的是,在本文中,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者装置不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者装置所固有的要素。在没有更多限制的情况下,由语句“包括一个……”限定的要素,并不排除在包括该要素的过程、方法、物品或者装置中还存在另外的相同要素。It should be noted that in this article, the terms "include", "include" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements not only includes those elements, It also includes other elements not explicitly listed, or elements inherent to the process, method, article, or device. If there are no more restrictions, the element defined by the sentence "including a..." does not exclude the existence of other identical elements in the process, method, article, or device that includes the element.
在本发明所提供的几个实施例中,应该理解到,所揭露的设备和方法,可以通过其它的方式实现。以上所描述的设备实施例仅仅是示意性的,例如,所述单元的划分,仅仅为一种逻辑功能划分,实际实现时可以有另外的划分方式,如:多个单元或组件可以结合,或可以集成到另一个系统,或一些特征可以忽略,或不执行。另外,所显示或讨论的各组成部分相互之间的耦合、或直接耦合、或通信连接可以是通过一些接口,设备或单元的间接耦合或通信连接,可以是电性的、机械的或其它形式的。In the several embodiments provided by the present invention, it should be understood that the disclosed device and method may be implemented in other ways. The device embodiments described above are merely illustrative. For example, the division of the units is only a logical function division, and there may be other divisions in actual implementation, such as: multiple units or components can be combined, or It can be integrated into another system, or some features can be ignored or not implemented. In addition, the coupling, or direct coupling, or communication connection between the components shown or discussed may be indirect coupling or communication connection through some interfaces, devices or units, and may be in electrical, mechanical or other forms. of.
上述作为分离部件说明的单元可以是、或也可以不是物理上分开的,作为单元显示的部件可以是、或也可以不是物理单元;既可以位于一个地方,也可以分布到多个网络单元上;可以根据实际的需要选择其中的部分或全部单元来实现本实施例方案的目的。The units described above as separate components may or may not be physically separate, and the components displayed as units may or may not be physical units; they may be located in one place or distributed on multiple network units; Some or all of the units may be selected according to actual needs to achieve the purpose of the solution of the embodiment.
另外,在本发明各实施例中的各功能单元可以全部集成在一个处理单元中,也可以是各单元分别单独作为一个单元,也可以两个或两个以上单 元集成在一个单元中;上述集成的单元既可以采用硬件的形式实现,也可以采用硬件加软件功能单元的形式实现。In addition, the functional units in the embodiments of the present invention can be all integrated into one processing unit, or each unit can be individually used as a unit, or two or more units can be integrated into one unit; the above-mentioned integration The unit can be implemented in the form of hardware, or in the form of hardware plus software functional units.
本领域普通技术人员可以理解:实现上述方法实施例的全部或部分步骤可以通过程序指令相关的硬件来完成,前述的程序可以存储于计算机可读取存储介质中,该程序在执行时,执行包括上述方法实施例的步骤;而前述的存储介质包括:移动存储设备、只读存储器(Read Only Memory,ROM)、磁碟或者光盘等各种可以存储程序代码的介质。Those of ordinary skill in the art can understand that all or part of the steps in the above method embodiments can be implemented by a program instructing relevant hardware. The foregoing program can be stored in a computer readable storage medium. When the program is executed, the execution includes The steps of the foregoing method embodiment; and the foregoing storage medium includes: various media that can store program codes, such as a removable storage device, a read only memory (Read Only Memory, ROM), a magnetic disk, or an optical disk.
或者,本发明上述集成的单元如果以软件功能模块的形式实现并作为独立的产品销售或使用时,也可以存储在一个计算机可读取存储介质中。基于这样的理解,本发明实施例的技术方案本质上或者说对现有技术做出贡献的部分可以以软件产品的形式体现出来,该计算机软件产品存储在一个存储介质中,包括若干指令用以使得一台计算机设备(可以是个人计算机、服务器、或者网络设备等)执行本发明各个实施例所述方法的全部或部分。而前述的存储介质包括:移动存储设备、ROM、磁碟或者光盘等各种可以存储程序代码的介质。Alternatively, if the aforementioned integrated unit of the present invention is implemented in the form of a software function module and sold or used as an independent product, it can also be stored in a computer readable storage medium. Based on this understanding, the technical solutions of the embodiments of the present invention can be embodied in the form of a software product in essence or a part that contributes to the prior art. The computer software product is stored in a storage medium and includes several instructions for A computer device (which may be a personal computer, a server, or a network device, etc.) executes all or part of the methods described in the various embodiments of the present invention. The aforementioned storage media include: removable storage devices, ROMs, magnetic disks or optical discs and other media that can store program codes.
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应以所述权利要求的保护范围为准。The above are only specific embodiments of the present invention, but the protection scope of the present invention is not limited thereto. Any person skilled in the art can easily think of changes or substitutions within the technical scope disclosed by the present invention. It should be covered within the protection scope of the present invention. Therefore, the protection scope of the present invention should be subject to the protection scope of the claims.
Claims (19)
- 一种动物血液细胞分析方法,应用于动物血液细胞分析仪,所述方法包括:An animal blood cell analysis method, applied to an animal blood cell analyzer, the method comprising:从多种动物测量模式中选中目标测量模式,并根据所述目标测量模式确定稀释液的目标剂量;Select a target measurement mode from a variety of animal measurement modes, and determine the target dose of the diluent according to the target measurement mode;将所述目标剂量的稀释液与待测动物血液进行混合并进行溶血处理,得到检测样本;Mixing the diluent of the target dose with the blood of the animal to be tested and performing hemolysis treatment to obtain a test sample;对所述检测样本进行测试,得到白细胞计数和分类结果。The test sample is tested to obtain white blood cell count and classification results.
- 根据权利要求1所述的方法,其中,从多种动物测量模式中选中目标测量模式,包括:The method according to claim 1, wherein selecting the target measurement mode from a plurality of animal measurement modes includes:输出动物测量模式选择界面;Output animal measurement mode selection interface;接收针对所述测量模式选择界面中的动物测量模式的输入操作或选择操作;Receiving an input operation or selection operation for the animal measurement mode in the measurement mode selection interface;根据所述输入操作或所述选择操作从多种动物测量模式中确定目标测量模式。The target measurement mode is determined from a plurality of animal measurement modes according to the input operation or the selection operation.
- 根据权利要求1所述的方法,其中,从多种动物测量模式中选中目标测量模式,包括:The method according to claim 1, wherein selecting the target measurement mode from a plurality of animal measurement modes includes:扫描盛放所述待测动物血液的试管上的信息标识,得到所述待测动物血液的样本信息;Scan the information identifier on the test tube containing the blood of the animal to be tested to obtain sample information of the blood of the animal to be tested;根据所述样本信息,从多种动物测量模式中选中目标测量模式。According to the sample information, the target measurement mode is selected from a plurality of animal measurement modes.
- 根据权利要求1所述的方法,其中,将所述目标剂量的稀释液与待测动物血液进行混合并进行溶血处理,得到检测样本,包括:The method according to claim 1, wherein mixing the diluent of the target dose with the blood of the animal to be tested and performing hemolysis treatment to obtain a test sample comprises:向第一计数池组件中加入目标剂量的稀释液;Adding the diluent of the target dose to the first counting cell assembly;向所述第一计数池组件中加入溶血剂和所述待测动物血液,得到检测 样本。The hemolytic agent and the blood of the animal to be tested are added to the first counting cell assembly to obtain a test sample.
- 根据权利要求1所述的方法,其中,所述将所述目标剂量的稀释液与待测动物血液进行混合并进行溶血处理,包括:The method according to claim 1, wherein the mixing the target dose of the diluent with the blood of the animal to be tested and performing hemolysis treatment comprises:向第一剂量的稀释液中加入所述待测动物血液,得到参考检测样本;Adding the blood of the animal to be tested to the first dose of diluent to obtain a reference test sample;向所述参考检测样本中加入第二剂量的稀释液和溶血剂,得到所述检测样本,所述第一剂量和所述第二剂量的和为所述目标剂量。A second dose of diluent and hemolytic agent are added to the reference test sample to obtain the test sample, and the sum of the first dose and the second dose is the target dose.
- 根据权利要求5所述的方法,其中,在向所述参考检测样本中加入第二剂量的稀释液和溶血剂之前,所述方法还包括:The method according to claim 5, wherein, before adding a second dose of diluent and hemolytic agent to the reference test sample, the method further comprises:从所述参考检测样本中吸取固定剂量的所述参考检测样本;Drawing a fixed dose of the reference test sample from the reference test sample;对所述固定剂量的所述参考检测样本进行红细胞测试和/或血小板测试。Red blood cell test and/or platelet test are performed on the reference test sample of the fixed dose.
- 根据权利要求5或6所述的方法,其中,对于不同的动物测量模式,所述第一剂量相同。The method according to claim 5 or 6, wherein the first dose is the same for different animal measurement modes.
- 根据权利要求5所述的方法,其中,所述向第一剂量的稀释液中加入所述待测动物血液,得到参考检测样本,包括:The method according to claim 5, wherein the adding the blood of the test animal to the first dose of diluent to obtain a reference test sample comprises:向第一计数池组件中加入第一剂量的稀释液;Adding the first dose of diluent to the first counting cell assembly;向所述第一计数池组件中加入所述待测动物血液,得到参考检测样本。The blood of the animal to be tested is added to the first counting cell assembly to obtain a reference test sample.
- 根据权利要求5所述的方法,其中,所述向第一剂量的稀释液中加入所述待测动物血液,得到参考检测样本,包括:The method according to claim 5, wherein the adding the blood of the test animal to the first dose of diluent to obtain a reference test sample comprises:向第一计数池组件中加入第三剂量的稀释液;Add a third dose of diluent to the first counting cell assembly;向所述第一计数池组件加入第四剂量的稀释液和所述待测动物血液,得到参考检测样本,所述第三剂量和所述第四剂量的和为所述第一剂量。A fourth dose of diluent and the blood of the animal to be tested are added to the first counting cell assembly to obtain a reference test sample, and the sum of the third dose and the fourth dose is the first dose.
- 一种动物血液细胞分析仪,所述动物血液细胞分析仪,包括:An animal blood cell analyzer. The animal blood cell analyzer includes:采样针组件,用于吸取待测动物血液并送至第一计数池组件;The sampling needle assembly is used to suck the blood of the animal to be tested and send it to the first counting cell assembly;模式选择模块,用于从多种动物测量模式中选中目标测量模式,并根 据所述目标测量模式确定稀释液的目标剂量;The mode selection module is used to select a target measurement mode from multiple animal measurement modes, and determine the target dose of the diluent according to the target measurement mode;试剂输送组件,用于将所述目标剂量的稀释液与所述待测动物血液进行混合,并进行溶血处理,得到检测样本;A reagent delivery component, which is used to mix the diluent of the target dose with the blood of the animal to be tested, and perform hemolysis treatment to obtain a test sample;第一计数池组件,用于对所述检测样本进行测试,得到白细胞计数和分类结果。The first counting cell component is used to test the test sample to obtain the white blood cell count and classification results.
- 根据权利要求10所述的动物血液细胞分析仪,其中,所述动物血液细胞分析仪还包括:显示器和输入装置;The animal blood cell analyzer according to claim 10, wherein the animal blood cell analyzer further comprises: a display and an input device;所述显示器,用于输出动物测量模式选择界面;The display is used to output an animal measurement mode selection interface;所述输入装置,用于接收针对所述测量模式选择界面中的动物测量模式的输入操作或选择操作;The input device is configured to receive input operations or selection operations for the animal measurement mode in the measurement mode selection interface;所述模式选择模块,用于根据所述输入操作或所述选择操作从多种动物测量模式中确定目标测量模式。The mode selection module is configured to determine a target measurement mode from multiple animal measurement modes according to the input operation or the selection operation.
- 根据权利要求10所述的动物血液细胞分析仪,其中,所述动物血液细胞分析仪还包括:扫描仪;The animal blood cell analyzer according to claim 10, wherein the animal blood cell analyzer further comprises: a scanner;所述扫描仪,用于扫描盛放所述待测动物血液的试管上的信息标识,得到所述待测动物血液的样本信息;The scanner is used to scan the information identifier on the test tube containing the blood of the animal to be tested to obtain sample information of the blood of the animal to be tested;所述模式选择模块,用于根据所述样本信息,从多种动物测量模式中选中目标测量模式。The mode selection module is used to select a target measurement mode from multiple animal measurement modes according to the sample information.
- 根据权利要求10所述的动物血液细胞分析仪,其中,所述试剂输送组件,还用于:The animal blood cell analyzer according to claim 10, wherein the reagent delivery component is also used for:向所述第一计数池组件中加入目标剂量的稀释液,并向所述第一计数池组件中加入溶血剂。Adding a target dose of diluent to the first counting cell component, and adding a hemolytic agent to the first counting cell component.
- 根据权利要求10所述的动物血液细胞分析仪,其中,The animal blood cell analyzer according to claim 10, wherein:所述试剂输送组件,还用于在所述采样针组件将所述待测动物血液送入所述第一计数池中之前或之时,向所述第一计数池组件中加入第一剂量 的稀释液;The reagent delivery assembly is also used to add a first dose of the first counting pool to the first counting pool before or when the sampling needle assembly sends the blood of the animal to be tested into the first counting pool. Diluent;所述试剂输送组件,还用于在所述采样针组件向所述第一计数池组件中加入待测动物血液之后,向所述第一计数池组件中加入第二剂量的稀释液和溶血剂,所述第一剂量和所述第二剂量的和为所述目标剂量。The reagent delivery component is also used for adding a second dose of diluent and hemolytic agent to the first counting cell component after the sampling needle component adds the blood of the animal to be tested into the first counting cell component , The sum of the first dose and the second dose is the target dose.
- 根据权利要求14所述的动物血液细胞分析仪,其中,所述动物血液细胞分析仪还包括:第二计数池组件;The animal blood cell analyzer according to claim 14, wherein the animal blood cell analyzer further comprises: a second counting cell component;所述采样针组件还用于从所述第一计数池组件中吸取固定剂量的由所述第一剂量的稀释液和所述待测动物血液构成的参考检测样本,并送至所述第二计数池组件;The sampling needle assembly is also used to suck a fixed dose of a reference test sample composed of the first dose of diluent and the blood of the animal to be tested from the first counting cell assembly, and send it to the second Counting pool components;所述第二计数池组件,用于对所述固定剂量的所述参考检测样本进行红细胞测试和/或血小板测试。The second counting cell component is used to perform red blood cell test and/or platelet test on the fixed dose of the reference test sample.
- 根据权利要求14或15所述的动物血液细胞分析仪,其中,对于不同的动物测量模式,所述第一剂量相同。The animal blood cell analyzer according to claim 14 or 15, wherein the first dose is the same for different animal measurement modes.
- 根据权利要求14所述的动物血液细胞分析仪,其中,所述试剂输送组件,还用于在所述采样针组件将待测动物血液送入所述第一计数池组件之前,向所述第一计数池组件中加入第一剂量的稀释液。The animal blood cell analyzer according to claim 14, wherein the reagent delivery assembly is further used to send the blood of the animal to be tested into the first counting cell assembly before the sampling needle assembly A first dose of diluent is added to a counting cell assembly.
- 根据权利要求14所述的动物血液细胞分析仪,其中,所述试剂输送组件,还用于:The animal blood cell analyzer according to claim 14, wherein the reagent delivery component is also used for:在所述采样针组件将待测动物血液送入所述第一计数池组件之前,向第一计数池组件中加入第三剂量的稀释液;Before the sampling needle assembly sends the blood of the animal to be tested into the first counting pool assembly, adding a third dose of diluent to the first counting pool assembly;在所述采样针组件将待测动物血液送入所述第一计数池组件之时,向所述第一计数池组件中加入第四剂量的稀释液,所述第三剂量和所述第四剂量的和为所述第一剂量。When the sampling needle assembly sends the blood of the animal to be tested into the first counting cell assembly, a fourth dose of diluent is added to the first counting cell assembly, and the third dose and the fourth The sum of the doses is the first dose.
- 一种存储介质,所述存储介质上存储有可执行程序,所述可执行程序被处理器执行时,实现权利要求1至9任一项所述的动物血液细胞分 析方法的步骤。A storage medium having an executable program stored on the storage medium, and when the executable program is executed by a processor, the steps of the animal blood cell analysis method according to any one of claims 1 to 9 are realized.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2019/106669 WO2021051349A1 (en) | 2019-09-19 | 2019-09-19 | Method for analysis of animal blood cells, analyzer, and storage medium |
CN201980098599.8A CN114174826A (en) | 2019-09-19 | 2019-09-19 | Animal blood cell analysis method, analyzer and storage medium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2019/106669 WO2021051349A1 (en) | 2019-09-19 | 2019-09-19 | Method for analysis of animal blood cells, analyzer, and storage medium |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021051349A1 true WO2021051349A1 (en) | 2021-03-25 |
Family
ID=74883019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2019/106669 WO2021051349A1 (en) | 2019-09-19 | 2019-09-19 | Method for analysis of animal blood cells, analyzer, and storage medium |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN114174826A (en) |
WO (1) | WO2021051349A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113125785A (en) * | 2021-03-29 | 2021-07-16 | 深圳市科曼医疗设备有限公司 | Method for detecting high-concentration sample and calling time sequence |
CN113777009A (en) * | 2021-08-31 | 2021-12-10 | 深圳迈瑞动物医疗科技有限公司 | Cell analyzer suitable for sheep, goats and cows and cell detection method |
WO2023028835A1 (en) * | 2021-08-31 | 2023-03-09 | 深圳迈瑞动物医疗科技股份有限公司 | Specimen analysis apparatus and specimen analysis method |
CN116298348A (en) * | 2023-05-17 | 2023-06-23 | 深圳迈瑞动物医疗科技股份有限公司 | Blood analysis device and method for species |
CN116359525A (en) * | 2023-06-01 | 2023-06-30 | 深圳市帝迈生物技术有限公司 | Blood analysis device and control method thereof |
WO2024234317A1 (en) * | 2023-05-17 | 2024-11-21 | 深圳迈瑞动物医疗科技股份有限公司 | Blood analysis apparatus and method for species |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1247982A (en) * | 1998-08-04 | 2000-03-22 | Abx公司 | Reagent for measurement of hemoglobin and determination of leukocytes in a blood sample |
WO2002014861A1 (en) * | 2000-08-17 | 2002-02-21 | Mallinckrodt Baker B.V. | Method and reagent for the analysis of blood samples, in particular for veterinary applications |
US6391263B1 (en) * | 1999-02-26 | 2002-05-21 | Sysmex Corporation | Automated analyzing system and method therefor |
CN1811417A (en) * | 2005-01-24 | 2006-08-02 | 希森美康株式会社 | Method and reagent for classifying leukocytes in animal blood |
CN101189503A (en) * | 2005-03-31 | 2008-05-28 | C2诊断公司 | Optical device for blood analysis, analyzing apparatus equipped with same |
CN101470109A (en) * | 2007-12-25 | 2009-07-01 | 深圳迈瑞生物医疗电子股份有限公司 | Method for improving accuracy of blood sample leukocyte classifying result |
CN102016573A (en) * | 2008-05-09 | 2011-04-13 | 希森美康株式会社 | Blood analyzer, blood analysis method, hemolytic agent and staining agent |
CN106370584A (en) * | 2016-08-17 | 2017-02-01 | 江苏英诺华医疗技术有限公司 | Blood corpuscle detection and biochemical detection instrument and detection method thereof |
CN108872225A (en) * | 2018-07-17 | 2018-11-23 | 浙江亚培生物技术有限公司 | A kind of detection reagent and detection method detecting animal blood cell |
CN109270281A (en) * | 2017-07-18 | 2019-01-25 | 深圳市帝迈生物技术有限公司 | Improve the method and apparatus of leukocyte differential count result accuracy and count results repeatability |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5262329A (en) * | 1991-06-13 | 1993-11-16 | Carver Jr Edward L | Method for improved multiple species blood analysis |
US20030008410A1 (en) * | 1995-03-13 | 2003-01-09 | Hechinger Mark K. | Immunoassay apparatus, kit and methods |
-
2019
- 2019-09-19 WO PCT/CN2019/106669 patent/WO2021051349A1/en active Application Filing
- 2019-09-19 CN CN201980098599.8A patent/CN114174826A/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1247982A (en) * | 1998-08-04 | 2000-03-22 | Abx公司 | Reagent for measurement of hemoglobin and determination of leukocytes in a blood sample |
US6391263B1 (en) * | 1999-02-26 | 2002-05-21 | Sysmex Corporation | Automated analyzing system and method therefor |
WO2002014861A1 (en) * | 2000-08-17 | 2002-02-21 | Mallinckrodt Baker B.V. | Method and reagent for the analysis of blood samples, in particular for veterinary applications |
CN1811417A (en) * | 2005-01-24 | 2006-08-02 | 希森美康株式会社 | Method and reagent for classifying leukocytes in animal blood |
CN101189503A (en) * | 2005-03-31 | 2008-05-28 | C2诊断公司 | Optical device for blood analysis, analyzing apparatus equipped with same |
CN101470109A (en) * | 2007-12-25 | 2009-07-01 | 深圳迈瑞生物医疗电子股份有限公司 | Method for improving accuracy of blood sample leukocyte classifying result |
CN102016573A (en) * | 2008-05-09 | 2011-04-13 | 希森美康株式会社 | Blood analyzer, blood analysis method, hemolytic agent and staining agent |
CN106370584A (en) * | 2016-08-17 | 2017-02-01 | 江苏英诺华医疗技术有限公司 | Blood corpuscle detection and biochemical detection instrument and detection method thereof |
CN109270281A (en) * | 2017-07-18 | 2019-01-25 | 深圳市帝迈生物技术有限公司 | Improve the method and apparatus of leukocyte differential count result accuracy and count results repeatability |
CN108872225A (en) * | 2018-07-17 | 2018-11-23 | 浙江亚培生物技术有限公司 | A kind of detection reagent and detection method detecting animal blood cell |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113125785A (en) * | 2021-03-29 | 2021-07-16 | 深圳市科曼医疗设备有限公司 | Method for detecting high-concentration sample and calling time sequence |
CN113125785B (en) * | 2021-03-29 | 2024-02-27 | 深圳市科曼医疗设备有限公司 | Method for detecting high-concentration sample and invoking time sequence |
EP4174488A4 (en) * | 2021-08-31 | 2023-10-11 | Shenzhen Mindray Animal Medical Technology Co., Ltd. | Specimen analysis apparatus and specimen analysis method |
CN115843332A (en) * | 2021-08-31 | 2023-03-24 | 深圳迈瑞动物医疗科技股份有限公司 | Sample analysis device and sample analysis method |
WO2023028835A1 (en) * | 2021-08-31 | 2023-03-09 | 深圳迈瑞动物医疗科技股份有限公司 | Specimen analysis apparatus and specimen analysis method |
CN113777009A (en) * | 2021-08-31 | 2021-12-10 | 深圳迈瑞动物医疗科技有限公司 | Cell analyzer suitable for sheep, goats and cows and cell detection method |
CN115843332B (en) * | 2021-08-31 | 2024-04-05 | 深圳迈瑞动物医疗科技股份有限公司 | Sample analysis device and sample analysis method |
CN113777009B (en) * | 2021-08-31 | 2024-04-16 | 深圳迈瑞动物医疗科技股份有限公司 | Cell analyzer and cell detection method suitable for sheep, goats and cows |
US12078631B2 (en) | 2021-08-31 | 2024-09-03 | Shenzhen Mindray Animal Medical Technology Co., Ltd. | Sample analysis apparatus and sample analysis method |
CN116298348A (en) * | 2023-05-17 | 2023-06-23 | 深圳迈瑞动物医疗科技股份有限公司 | Blood analysis device and method for species |
WO2024234317A1 (en) * | 2023-05-17 | 2024-11-21 | 深圳迈瑞动物医疗科技股份有限公司 | Blood analysis apparatus and method for species |
CN116359525A (en) * | 2023-06-01 | 2023-06-30 | 深圳市帝迈生物技术有限公司 | Blood analysis device and control method thereof |
CN116359525B (en) * | 2023-06-01 | 2023-11-24 | 深圳市帝迈生物技术有限公司 | Blood analysis device and control method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN114174826A (en) | 2022-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2021051349A1 (en) | Method for analysis of animal blood cells, analyzer, and storage medium | |
CN105891090B (en) | Blood cell analyzer, body fluid analysis method, and control system therefor | |
CN106525666B (en) | Blood analysis device, blood analysis method and information processing unit | |
CN103278439B (en) | Sample analyzer and control system thereof | |
EP1953527B2 (en) | Sample analyzer and computer program product | |
JP6027742B2 (en) | Blood cell analyzer, blood cell analysis method, and computer program | |
US9328375B2 (en) | Blood analyzer, blood analysis method, hemolytic agent and staining agent | |
EP3260842B1 (en) | Hematological analyzer and method for analyzing a sample | |
US20200209224A1 (en) | Methods and apparatuses for identifying red blood cells infected by plasmodium | |
US11402370B2 (en) | Alarming method for platelet aggregation sample, blood cell analyzer and storage medium | |
JP3793685B2 (en) | Automatic analysis system and method | |
JP5452122B2 (en) | Specimen test apparatus, test information management apparatus, and test information output method | |
CN112114000A (en) | Cell analyzer, method for classifying leukocytes based on impedance method and computer-readable storage medium | |
CN205538976U (en) | Simple reliable five categorised analytical equipment of blood cell | |
Riond et al. | Performance evaluation of the S ysmex poc H‐100i VD iff hematology analyzer for analysis of canine, feline, equine, and bovine blood | |
CN111912978B (en) | Method and device for classifying and counting white blood cells and blood analyzer | |
CN115839912B (en) | Blood analysis device and method for animals | |
JP5909480B2 (en) | Specimen test apparatus and test information output method | |
US20220113238A1 (en) | Method for classifying and counting white blood cells, hematology analyzer, and computer readable storage medium | |
Dewi et al. | Analysis of Blood Sample Lysis Rate on Hemoglobin Examination Results Using Rayto RT. 7600 Auto Hematology Analyzer | |
CN119223849A (en) | Blood analyzer, blood analysis method, cell analysis reagent and use thereof | |
CN118475833A (en) | Blood cell analyzer, method and use of infection marker parameters | |
CN115201460A (en) | Blood analyzer, blood analyzing method, and storage medium | |
CN117529648B (en) | Sample analysis device and sample analysis method | |
WO2016196220A1 (en) | System and method for defining and utilizing flow cytometry protocols |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19945622 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19945622 Country of ref document: EP Kind code of ref document: A1 |